data_1oo9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1oo9 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.211 -0.94 0 N-CA-C 107.581 -1.266 . . . . 46.5 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -39.68 92.8 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.593 1.157 . . . . 74.25 113.9 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.0 m -127.01 -47.45 1.5 Allowed 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.324 0.861 . . . . 49.27 113.324 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.4 42.3 Favored Pre-proline 0 C--O 1.218 -0.583 0 N-CA-C 107.379 -1.341 . . . . 75.12 107.379 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.03 157.62 60.98 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.61 0.873 . . . . 43.64 110.871 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.48 154.19 7.53 Favored Glycine 0 C--O 1.216 -1.02 0 C-N-CA 120.34 -0.933 . . . . 36.28 112.98 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.5 pt -123.41 152.71 64.99 Favored Pre-proline 0 C--N 1.353 0.727 0 CA-C-O 119.125 -0.464 . . . . 31.13 111.806 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.51 -35.06 99.14 Favored 'Trans proline' 0 C--N 1.354 0.83 0 N-CA-C 116.308 1.619 . . . . 35.51 116.308 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -151.13 159.13 44.65 Favored 'General case' 0 C--O 1.213 -0.837 0 O-C-N 123.77 0.669 . . . . 40.67 110.209 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -74.58 130.58 39.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.178 -1.045 . . . . 36.65 108.178 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.5 mtm-85 -83.75 36.52 0.55 Allowed 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.417 1.265 . . . . 67.01 114.417 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -161.7 154.28 20.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 106.987 -1.486 . . . . 37.65 106.987 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.16 -30.01 14.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.215 1.191 . . . . 32.41 114.215 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.402 ' HA ' ' OG1' ' A' ' 131' ' ' THR . 50.0 m-70 -95.35 99.1 11.08 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.983 -1.008 . . . . 29.52 110.397 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.08 155.3 16.81 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 122.801 1.286 . . . . 37.17 111.857 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -121.98 147.51 45.96 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 113.106 -1.861 . . . . 42.06 107.964 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -144.8 161.03 40.26 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 123.466 0.479 . . . . 45.39 111.303 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -143.27 134.5 25.9 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.884 0.698 . . . . 41.0 112.884 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mt -89.59 86.41 2.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 107.789 -1.189 . . . . 31.84 107.789 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 49.8 t -43.8 -62.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 116.3 1.963 . . . . 47.07 116.3 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -132.37 177.15 7.81 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.486 -0.561 . . . . 50.17 109.486 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -120.23 156.47 31.11 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.334 1.235 . . . . 50.94 114.334 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -92.12 133.61 29.97 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.407 -1.724 . . . . 54.6 109.429 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -60.22 -41.69 48.89 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 120.355 0.703 . . . . 58.5 110.596 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -31.55 -44.38 0.07 Allowed 'General case' 0 C--N 1.348 0.536 0 O-C-N 125.238 1.586 . . . . 65.73 112.799 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.2 tp -128.38 145.2 54.84 Favored Pre-proline 0 C--O 1.215 -0.747 0 N-CA-C 116.331 1.974 . . . . 57.13 116.331 -176.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -56.42 130.86 42.31 Favored 'Trans proline' 0 CA--C 1.504 -0.996 0 C-N-CA 122.498 2.132 . . . . 52.25 111.285 178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -37.82 -49.59 1.2 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.361 1.245 . . . . 60.36 114.361 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.0 -30.33 64.08 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.631 1.345 . . . . 66.06 114.631 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.51 -27.99 56.22 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.159 0.8 . . . . 48.74 113.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.91 -45.68 90.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 108.608 -0.886 . . . . 46.18 108.608 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.9 -40.45 73.04 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.931 -1.031 . . . . 40.22 109.913 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.5 t -63.7 -50.48 69.0 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.995 0.426 . . . . 46.59 111.122 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.66 -51.31 70.33 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 112.751 0.649 . . . . 41.77 112.751 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.26 -48.41 88.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-O 121.816 0.817 . . . . 36.84 111.96 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -45.16 84.99 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.434 -0.506 . . . . 54.09 112.327 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.675 ' HG3' ' CE1' ' A' ' 196' ' ' PHE . 17.7 tptt -58.56 -38.73 78.47 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 107.381 -1.34 . . . . 45.17 107.381 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -53.83 -54.91 31.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 114.695 1.369 . . . . 37.29 114.695 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.27 -39.78 83.97 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 114.249 -1.341 . . . . 29.23 113.541 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -56.58 -35.85 68.68 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.745 -0.661 . . . . 55.13 111.804 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.401 ' CG1' HD11 ' A' ' 234' ' ' LEU . 57.8 t -49.86 -38.69 14.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.494 -0.321 . . . . 38.03 111.685 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -86.72 -26.29 24.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.96 1.096 . . . . 40.81 113.96 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.37 -35.47 79.41 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.559 0.695 . . . . 58.31 112.004 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.41 -33.98 75.84 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.799 -0.637 . . . . 59.17 112.151 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.42 ' C ' HG21 ' A' ' 128' ' ' THR . 20.2 m -94.79 3.96 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 115.688 1.736 . . . . 41.49 115.688 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.42 HG21 ' C ' ' A' ' 127' ' ' VAL . 59.0 p -146.68 174.38 3.45 Favored Pre-proline 0 C--O 1.218 -0.562 0 CA-C-O 118.574 -0.727 . . . . 38.06 110.562 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -86.01 14.6 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 120.861 1.041 . . . . 38.9 114.242 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 20.2 mt -74.07 148.89 41.48 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 113.51 0.93 . . . . 36.84 113.51 -177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 96' ' ' HIS . 37.9 p -130.24 147.63 51.98 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.966 1.416 . . . . 43.68 108.089 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -129.11 121.91 28.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.36 1.037 . . . . 49.06 111.543 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.5 p -112.26 125.97 54.73 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.193 -0.912 . . . . 59.95 109.595 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -80.24 142.89 34.2 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.914 -0.714 . . . . 55.05 111.55 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.98 166.33 17.13 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.986 -1.116 . . . . 42.22 107.986 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -133.91 5.79 3.64 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.58 0.956 . . . . 48.17 113.58 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.74 154.46 24.35 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.183 -1.784 . . . . 84.4 106.183 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.47 54.19 Favored Glycine 0 C--O 1.217 -0.94 0 C-N-CA 119.705 -1.236 . . . . 53.5 110.54 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -99.98 116.69 32.61 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 121.742 0.782 . . . . 64.75 110.691 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.07 176.7 6.88 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.415 -1.698 . . . . 48.66 106.415 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -69.33 -57.77 4.88 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.391 -1.337 . . . . 40.71 107.391 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.76 104.2 15.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-N 113.873 -1.512 . . . . 29.43 110.815 -177.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 20.4 mmm -91.95 102.11 14.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.719 -1.128 . . . . 54.61 109.387 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 51.6 mt -89.84 133.25 32.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 115.492 -0.777 . . . . 38.97 110.322 179.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.2 p -159.85 156.07 26.77 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 115.842 1.793 . . . . 41.52 115.842 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -103.67 139.38 39.01 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.858 -1.065 . . . . 38.09 110.369 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -151.51 171.57 17.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.282 -0.872 . . . . 35.45 110.279 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.88 140.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 106.939 -1.504 . . . . 40.45 106.939 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 47.05 -128.57 1.58 Allowed 'General case' 0 C--O 1.215 -0.725 0 O-C-N 123.677 0.611 . . . . 43.41 110.677 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -67.41 130.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.897 0.772 . . . . 86.59 111.057 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 41.2 p-80 -147.85 33.34 0.84 Allowed 'General case' 0 C--N 1.352 0.717 0 N-CA-C 117.608 2.447 . . . . 51.03 117.608 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.21 -64.92 0.25 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 116.113 1.205 . . . . 54.35 116.113 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -73.14 176.61 5.69 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.045 0.45 . . . . 51.74 111.186 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.24 18.44 1.74 Allowed 'General case' 0 C--N 1.348 0.508 0 N-CA-C 115.078 1.511 . . . . 55.0 115.078 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -133.54 82.3 51.96 Favored Pre-proline 0 C--O 1.218 -0.566 0 C-N-CA 119.554 -0.859 . . . . 37.59 111.656 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -62.36 147.88 94.19 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.189 1.926 . . . . 46.32 112.269 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -81.72 148.6 28.88 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.953 -1.021 . . . . 45.8 110.837 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -84.05 30.89 0.5 Allowed 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 119.488 3.144 . . . . 45.02 119.488 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.487 ' HA2' ' OD2' ' A' ' 183' ' ' ASP . . . 70.65 -165.7 52.13 Favored Glycine 0 C--O 1.218 -0.886 0 C-N-CA 117.34 -2.362 . . . . 51.0 112.722 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -62.52 141.71 87.46 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 CA-C-N 120.14 1.97 . . . . 42.9 113.954 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 82.96 -172.49 51.65 Favored Glycine 0 C--O 1.217 -0.96 0 CA-C-N 115.053 -0.976 . . . . 44.14 115.471 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 50.39 -104.54 0.16 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 113.435 -1.383 . . . . 51.46 114.605 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.6 t -84.22 111.14 19.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 CA-C-O 121.224 0.535 . . . . 41.2 111.102 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.407 ' N ' HD13 ' A' ' 164' ' ' LEU . 0.4 OUTLIER -86.48 -27.57 23.98 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 114.272 1.212 . . . . 34.63 114.272 -176.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -172.92 163.22 4.86 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 123.893 0.746 . . . . 35.16 112.584 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -144.89 161.41 39.38 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 124.753 1.283 . . . . 36.41 110.775 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 164.46 34.63 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.849 -0.614 . . . . 27.48 112.231 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -114.71 154.43 28.48 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.802 -1.09 . . . . 41.88 113.155 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.01 164.36 61.72 Favored Pre-proline 0 C--O 1.206 -1.201 0 CA-C-O 117.293 -1.337 . . . . 28.07 113.948 -178.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -49.27 151.4 6.54 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 O-C-N 123.253 1.133 . . . . 25.56 112.844 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 146.98 -177.7 25.09 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 119.824 -1.179 . . . . 31.26 115.578 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.37 153.49 31.21 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.49 1.46 . . . . 41.64 114.264 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.97 -120.51 10.75 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 117.965 1.946 . . . . 40.28 117.965 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.4 tt -68.41 -12.36 15.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 112.767 0.655 . . . . 42.55 112.767 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -63.98 150.67 44.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.507 0.67 . . . . 36.9 112.366 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.17 3.13 Favored Glycine 0 C--O 1.214 -1.113 0 C-N-CA 120.06 -1.067 . . . . 28.23 114.376 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.74 158.06 25.8 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.341 0.591 . . . . 34.02 112.271 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -137.42 128.79 28.08 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.749 -1.114 . . . . 35.07 108.403 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -114.53 150.35 35.04 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.269 -0.641 . . . . 38.37 109.269 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PHE . . . . . 0.583 ' CE2' ' OE2' ' A' ' 202' ' ' GLU . 61.7 m-85 -129.35 137.45 50.98 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 124.812 1.32 . . . . 40.68 113.304 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -74.41 103.78 4.9 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.322 -0.853 . . . . 45.33 111.814 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -65.6 -26.06 67.67 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 113.934 1.087 . . . . 53.78 113.934 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.487 ' OD2' ' HA2' ' A' ' 159' ' ' GLY . 47.4 m-20 -58.6 -13.46 5.82 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 115.334 -0.848 . . . . 51.05 112.05 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -86.03 165.17 16.89 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.111 -1.07 . . . . 45.57 108.111 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -96.36 99.58 11.25 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 106.304 -1.739 . . . . 64.01 106.304 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -80.47 126.25 30.97 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.901 -1.045 . . . . 48.68 112.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 26.5 p -135.93 149.77 49.06 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.76 0.663 . . . . 51.42 111.024 179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -90.76 8.53 34.19 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.981 -1.009 . . . . 86.48 111.102 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.18 179.34 6.38 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 120.443 -0.503 . . . . 68.59 110.978 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 1.5 m -78.18 51.91 1.05 Allowed 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.512 -0.767 . . . . 78.8 112.868 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 23.4 m -151.06 59.27 0.91 Allowed 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 108.41 -0.959 . . . . 88.97 108.41 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 147.61 -162.39 28.68 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.869 -1.692 . . . . 72.91 108.869 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 40.6 m -89.56 104.88 17.4 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 119.557 -0.857 . . . . 57.28 108.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.418 ' OD1' ' HB3' ' A' ' 196' ' ' PHE . 16.5 t-20 -58.67 105.53 0.31 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.562 1.545 . . . . 53.61 113.838 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.51 -41.93 61.36 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.95 -1.023 . . . . 41.62 112.393 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PHE . . . . . 0.675 ' CE1' ' HG3' ' A' ' 119' ' ' LYS . 27.0 t80 -57.07 -57.45 12.53 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.194 0.521 . . . . 36.77 110.805 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 93.7 mt -48.23 -48.48 35.14 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 113.816 1.043 . . . . 38.23 113.816 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 42.7 t -67.61 -46.41 83.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 119.401 -0.92 . . . . 36.07 112.677 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.424 ' O ' HG12 ' A' ' 203' ' ' ILE . . . -58.18 -43.97 87.79 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.358 -0.937 . . . . 28.52 109.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.09 71.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.243 0.545 . . . . 27.22 111.013 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -65.26 -53.41 44.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.66 -1.154 . . . . 31.7 110.194 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE2' ' CE2' ' A' ' 180' ' ' PHE . 40.3 mt-10 -59.42 -39.57 83.91 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 113.565 0.95 . . . . 29.08 113.565 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 199' ' ' ALA . 2.5 mm -59.93 -36.98 70.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-O 121.973 0.892 . . . . 35.0 108.979 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLY . . . . . 0.401 ' O ' ' HB2' ' A' ' 209' ' ' LEU . . . -52.28 -35.74 43.64 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 120.329 -1.482 . . . . 26.18 110.376 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -72.76 -40.78 65.73 Favored 'General case' 0 C--O 1.214 -0.81 0 O-C-N 122.285 -0.538 . . . . 31.29 111.561 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 52.3 p -58.59 -28.7 65.83 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.656 0.598 . . . . 29.49 112.534 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.62 -12.49 42.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 114.194 1.183 . . . . 27.39 114.194 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.54 10.18 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 116.853 1.501 . . . . 26.75 116.853 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 204' ' ' GLY . 1.4 mp -87.73 159.79 18.34 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.983 0.734 . . . . 29.88 112.983 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.31 179.05 4.15 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.5 -0.773 . . . . 36.67 108.941 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' HIS . . . . . 0.512 ' CE1' ' O ' ' B' ' 301' ' ' CYS . 7.2 m-70 -71.66 145.71 48.74 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 119.318 -0.953 . . . . 29.26 110.4 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 26.9 t -104.19 155.87 18.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.544 -1.207 . . . . 35.16 109.613 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.89 -24.47 17.71 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.762 -1.108 . . . . 47.39 108.285 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.36 111.6 2.71 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.626 -1.25 . . . . 50.72 107.626 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.401 ' HA ' ' CD1' ' A' ' 220' ' ' TYR . 37.8 p -59.61 -24.47 63.83 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 114.512 1.301 . . . . 47.4 114.512 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -13.74 56.75 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.973 0.796 . . . . 67.68 112.75 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.75 134.9 37.02 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.94 0.718 . . . . 42.19 112.94 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.75 -41.04 63.65 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.083 0.468 . . . . 35.84 110.43 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 80.2 mmm -66.51 4.49 0.75 Allowed 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 115.277 1.584 . . . . 40.82 115.277 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . 0.401 ' CD1' ' HA ' ' A' ' 215' ' ' THR . 59.5 t80 -72.59 127.67 89.58 Favored Pre-proline 0 C--O 1.217 -0.619 0 N-CA-C 103.469 -2.789 . . . . 36.39 103.469 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.36 -30.69 29.67 Favored 'Trans proline' 0 C--O 1.202 -1.309 0 N-CA-C 117.511 2.081 . . . . 31.29 117.511 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.456 ' HA ' ' O ' ' B' ' 303' ' ' CYS . 3.3 mt -71.44 111.17 6.54 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 121.245 -0.909 . . . . 34.61 112.633 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -57.12 105.66 0.25 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.689 0.795 . . . . 51.64 112.451 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -96.53 13.93 26.41 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 117.693 2.479 . . . . 79.15 117.693 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.0 p 15.4 105.45 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 120.426 3.491 . . . . 69.13 120.426 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 145.15 25.12 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-O 121.376 0.608 . . . . 76.42 112.597 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' THR . . . . . . . . . . . . . 5.3 m -54.55 -85.91 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 116.327 1.973 . . . . 87.39 116.327 -177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.55 113.9 18.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.284 -1.51 . . . . 85.17 109.511 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -34.94 79.26 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 113.241 0.83 . . . . 79.35 113.241 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.5 m -50.67 -35.18 29.59 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 115.339 1.607 . . . . 91.15 115.339 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -95.63 28.52 2.97 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.808 1.41 . . . . 89.33 114.808 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -67.2 138.15 56.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.63 -0.507 . . . . 78.88 109.63 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.89 146.61 34.23 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.627 -0.715 . . . . 85.07 110.511 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.401 HD11 ' CG1' ' A' ' 123' ' ' VAL . 6.3 tp -80.99 146.03 30.89 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.394 -0.821 . . . . 55.61 109.119 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.9 t -78.5 142.68 37.26 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.339 -1.345 . . . . 51.73 107.564 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -46.45 -47.96 19.02 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.698 -1.593 . . . . 46.32 106.698 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -46.95 -41.28 15.87 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.76 1.393 . . . . 50.84 114.76 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -68.69 -37.22 79.39 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.865 -0.734 . . . . 29.49 109.61 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ILE . . . . . . . . . . . . . 61.3 mt -63.4 -52.07 62.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.522 -0.763 . . . . 27.5 109.27 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -57.25 -34.83 69.01 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.01 -0.737 . . . . 34.45 109.01 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -66.64 -56.18 14.29 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 120.97 -0.633 . . . . 28.94 114.331 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . . . . . . . . . 10.1 tp -67.16 -35.99 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 114.134 1.161 . . . . 30.41 114.134 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.2 -31.58 66.01 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.787 -0.765 . . . . 43.41 112.946 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.4 p -62.49 -7.17 4.13 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.703 0.763 . . . . 35.1 112.164 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tp -108.91 -62.02 1.53 Allowed 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.5 -0.926 . . . . 33.03 108.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -99.48 4.8 46.22 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 116.975 2.213 . . . . 34.64 116.975 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 71.41 167.31 8.12 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.548 -1.14 . . . . 34.72 112.392 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.58 171.12 8.73 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.421 1.61 . . . . 38.66 111.245 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -65.83 143.69 74.44 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 119.226 0.759 . . . . 49.6 111.555 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 C-N-CA 124.092 3.195 . . . . 55.17 114.452 179.591 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' A' ' 211' ' ' HIS . 42.6 t . . . . . 0 CA--C 1.501 -0.934 0 CA-C-O 121.607 0.717 . . . . 30.8 110.081 . -175.675 113.366 99.563 100.296 2.057 100.774 -68.107 -43.833 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' THR . . . . . . . . . . . . . 14.1 t -129.21 147.63 51.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.595 -2.002 . . . . 30.08 105.595 178.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 222' ' ' LEU . 4.3 p -167.13 159.74 13.25 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 118.596 2.813 . . . . 44.0 118.596 -179.23 45.805 171.665 -97.282 93.562 2.062 116.014 -79.2 -29.754 2 2 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' VAL . . . . . 0.41 ' O ' ' CG1' ' B' ' 304' ' ' VAL . 8.0 p -100.26 115.77 65.13 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 105.709 -1.959 . . . . 32.83 105.709 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -64.24 162.11 31.39 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 120.487 0.791 . . . . 39.45 113.069 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.82 159.48 4.1 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 N-CA-C 109.548 -0.982 . . . . 36.37 109.548 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' HIS . . . . . 0.498 ' O ' HG21 ' B' ' 310' ' ' THR . 3.6 t-80 -70.52 149.96 95.58 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 103.195 -2.891 . . . . 34.84 103.195 172.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' PRO . . . . . 0.419 ' HG3' ' CE2' ' B' ' 401' ' ' PHE . 46.4 Cg_exo -51.08 -40.23 59.75 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 O-C-N 116.59 -2.374 . . . . 27.9 115.012 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.13 -48.02 83.47 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.939 -0.704 . . . . 30.49 112.503 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' THR . . . . . 0.498 HG21 ' O ' ' B' ' 307' ' ' HIS . 0.1 OUTLIER -62.97 -34.63 77.93 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.602 -0.839 . . . . 29.09 109.144 177.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' ALA . . . . . . . . . . . . . . . -59.28 -42.08 90.44 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.324 -0.621 . . . . 25.04 109.324 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' PHE . . . . . 0.489 ' CE1' HG21 ' B' ' 421' ' ' THR . 43.1 t80 -70.84 -46.89 61.89 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.032 0.753 . . . . 30.13 113.032 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' CYS . . . . . . . . . . . . . 63.7 m -65.88 -50.5 64.27 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 114.496 1.295 . . . . 32.62 114.496 -177.264 -57.164 -66.83 -75.929 103.578 2.031 104.161 -49.168 -62.326 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -76.11 -15.13 60.15 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 116.593 2.071 . . . . 35.09 116.593 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' SER . . . . . . . . . . . . . 74.9 m -75.94 163.12 27.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.379 -0.929 . . . . 29.75 110.065 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.44 -35.39 11.73 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.518 -0.765 . . . . 37.98 109.695 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' LEU . . . . . . . . . . . . . 8.2 mp -135.46 139.92 44.46 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.623 -0.88 . . . . 32.72 108.623 178.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.66 89.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 102.441 -3.17 . . . . 34.35 102.441 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ILE . . . . . 0.419 ' CD1' ' HG3' ' B' ' 345' ' ' MET . 1.0 OUTLIER -95.15 166.58 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 111.524 -2.58 . . . . 42.68 111.342 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -127.14 130.91 50.69 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 101.423 -3.547 . . . . 39.88 101.423 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.0 176.95 11.25 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 114.229 1.196 . . . . 34.71 114.229 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -121.23 144.46 48.6 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 107.506 -1.294 . . . . 45.62 107.506 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -82.66 109.93 17.27 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 44.22 110.721 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.28 -35.84 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 124.655 1.222 . . . . 53.29 114.278 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . -134.99 160.3 24.27 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 118.658 -1.734 . . . . 49.61 115.617 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -72.84 153.65 91.16 Favored Pre-proline 0 C--O 1.218 -0.586 0 CA-C-N 114.112 -1.044 . . . . 46.4 110.467 176.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.81 136.01 73.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 N-CA-C 117.617 2.122 . . . . 44.33 117.617 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.3 138.38 29.49 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 114.077 -1.42 . . . . 65.85 109.322 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' VAL . . . . . 0.452 HG12 ' O ' ' B' ' 332' ' ' THR . 5.2 t -74.91 114.81 15.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.531 -0.914 . . . . 56.13 108.531 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' ASN . . . . . 0.852 ' ND2' ' CZ ' ' B' ' 337' ' ' ARG . 26.5 t-20 -74.0 -111.56 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 O-C-N 123.859 0.724 . . . . 53.1 112.762 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLN . . . . . 0.676 ' N ' ' OD1' ' B' ' 330' ' ' ASN . 2.4 pt20 -104.92 25.15 10.83 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.497 -0.752 . . . . 58.24 110.716 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' THR . . . . . 0.452 ' O ' HG12 ' B' ' 329' ' ' VAL . 47.5 m -156.0 136.29 13.04 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 118.636 -0.697 . . . . 50.46 109.783 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' THR . . . . . . . . . . . . . 71.7 m -69.92 -23.47 63.23 Favored 'General case' 0 C--O 1.207 -1.173 0 O-C-N 124.091 0.869 . . . . 54.23 112.761 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' LEU . . . . . . . . . . . . . 18.9 mt -70.37 -32.58 70.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 116.285 1.957 . . . . 40.93 116.285 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.99 146.55 49.36 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 119.591 -0.844 . . . . 39.28 110.469 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' GLN . . . . . 0.428 ' HG3' ' HA ' ' B' ' 365' ' ' ALA . 12.7 mt-30 -110.69 148.04 33.11 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.006 -2.59 . . . . 60.94 104.006 175.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' ARG . . . . . 0.852 ' CZ ' ' ND2' ' B' ' 330' ' ' ASN . 25.9 ptt180 -128.85 149.31 50.81 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 118.937 -1.105 . . . . 47.85 113.606 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' TYR . . . . . 0.45 ' HB2' ' CG1' ' B' ' 361' ' ' VAL . 46.7 m-85 -111.83 133.73 53.85 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 124.736 1.273 . . . . 51.43 108.231 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.78 131.36 37.57 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 104.412 -2.44 . . . . 63.19 104.412 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.4 149.5 33.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 123.83 0.706 . . . . 44.14 112.364 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -106.68 100.43 9.95 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.893 -1.049 . . . . 73.27 108.973 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 3.7 ttp -73.94 119.14 17.74 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 117.481 2.4 . . . . 47.11 117.481 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' THR . . . . . . . . . . . . . 66.9 p -95.06 -77.82 0.46 Allowed 'General case' 0 C--O 1.216 -0.695 0 O-C-N 123.57 0.544 . . . . 46.76 110.983 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 141.89 35.12 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 118.677 -0.678 . . . . 66.84 111.156 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' MET . . . . . 0.419 ' HG3' ' CD1' ' B' ' 319' ' ' ILE . 6.6 ttm -117.59 110.35 17.81 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.586 -0.524 . . . . 36.2 109.586 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -85.28 -17.65 36.3 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.047 1.499 . . . . 44.05 115.047 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -157.81 151.3 23.62 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 120.423 -0.511 . . . . 32.99 112.318 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . 103.72 29.93 5.4 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.14 -0.936 . . . . 43.32 113.655 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.15 -3.19 2.52 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 114.454 1.279 . . . . 57.02 114.454 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.65 37.51 0.88 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 123.558 1.647 . . . . 82.34 108.687 170.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -163.37 8.89 0.05 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 126.601 1.961 . . . . 84.41 112.129 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' LEU . . . . . . . . . . . . 0.25 3.6 mm? 51.84 -106.22 0.26 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 116.062 1.875 . . . . 98.31 116.062 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 355' ' ' ALA . . . 100.22 -44.03 1.68 Allowed Glycine 1 N--CA 1.538 5.444 3 C-N-CA 110.885 -5.436 . . . . 89.8 125.273 -176.214 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 25.66 -66.65 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.672 1 CA-C-N 107.992 -4.104 . . . . 96.53 120.134 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 353' ' ' GLY . . . -157.51 -6.14 0.09 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.139 1.375 . . . . 77.39 111.325 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -168.05 45.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 114.378 1.251 . . . . 64.78 114.378 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -104.92 -32.76 8.62 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 118.929 -1.108 . . . . 72.41 109.152 171.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.92 108.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 101.709 -3.441 . . . . 60.69 101.709 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -119.56 3.99 11.16 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.956 0.785 . . . . 83.62 112.912 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.93 137.18 26.01 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.392 -0.367 . . . . 58.06 111.21 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . 0.45 ' CG1' ' HB2' ' B' ' 338' ' ' TYR . 5.9 p -115.64 124.56 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 N-CA-C 106.135 -1.802 . . . . 35.98 106.135 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' TYR . . . . . 0.458 ' O ' HG23 ' B' ' 396' ' ' ILE . 6.0 m-85 -98.41 158.26 15.69 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.612 -0.722 . . . . 49.2 112.155 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' THR . . . . . 0.438 ' HB ' ' CG2' ' B' ' 396' ' ' ILE . 14.6 t -161.3 155.56 19.25 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.125 -1.805 . . . . 29.05 106.125 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.27 157.23 4.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 N-CA-C 115.858 1.445 . . . . 35.29 115.858 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . 0.428 ' HA ' ' HG3' ' B' ' 336' ' ' GLN . . . -62.61 -33.75 75.63 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 119.698 3.221 . . . . 36.61 119.698 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' MET . . . . . . . . . . . . . 13.7 ptm -131.99 139.88 48.78 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.284 -1.325 . . . . 47.92 113.523 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -49.84 -48.36 51.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.287 -0.87 . . . . 26.58 112.003 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' SER . . . . . . . . . . . . . 54.5 p -48.05 -32.69 7.01 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.817 0.673 . . . . 28.95 112.817 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -104.92 27.0 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 113.887 1.069 . . . . 29.93 113.887 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' CYS . . . . . . . . . . . . 0.337 7.9 m 91.94 6.81 0.06 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 121.52 3.896 . . . . 35.82 121.52 174.646 -43.833 -68.107 99.563 100.774 2.057 100.296 113.366 -175.675 2 2 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLY . . . . . . . . . . . . . . . -61.32 139.8 47.53 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 119.766 -1.207 . . . . 31.52 111.337 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -84.39 140.32 31.64 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 117.464 0.632 . . . . 39.89 111.157 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -119.92 107.71 13.46 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.285 1.587 . . . . 42.52 115.285 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.07 124.45 41.08 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 115.445 1.646 . . . . 49.33 115.445 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 74.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.582 1.697 . . . . 76.83 115.582 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 12.6 m -111.18 152.05 27.5 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 121.345 -0.847 . . . . 79.91 110.081 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -38.6 32.91 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.473 1.909 . . . . 93.97 116.018 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -103.76 114.44 28.71 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 122.852 0.461 . . . . 82.61 110.085 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -69.92 -19.98 63.37 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 117.769 2.507 . . . . 95.15 117.769 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' SER . . . . . . . . . . . . . 58.0 m -78.95 -5.09 52.89 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 113.37 0.878 . . . . 84.09 113.37 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -63.07 143.05 58.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.826 -0.624 . . . . 71.34 110.697 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.97 141.05 37.25 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 115.023 1.49 . . . . 60.79 115.023 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.61 156.89 33.33 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 113.541 -1.663 . . . . 45.22 114.394 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -108.08 112.79 25.51 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 103.378 -2.823 . . . . 35.22 103.378 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.25 119.17 59.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 106.632 -1.618 . . . . 22.07 106.632 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 386' ' ' ALA . . . . . . . . . . . . . . . -107.6 112.94 25.91 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.584 -2.006 . . . . 23.96 105.584 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 387' ' ' GLY . . . . . . . . . . . . . . . -136.42 171.8 22.73 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 118.439 -1.839 . . . . 24.77 116.088 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 388' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -99.46 169.41 9.34 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 114.399 -0.901 . . . . 36.06 110.288 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 389' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.8 99.46 6.54 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.425 -0.51 . . . . 47.22 109.786 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 390' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -89.29 125.19 35.01 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 102.127 -3.286 . . . . 65.61 102.127 173.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 391' ' ' ASP . . . . . . . . . . . . . 38.1 m-20 65.01 -126.42 0.37 Allowed 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 103.451 -2.796 . . . . 72.94 103.451 -173.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . -115.6 21.04 13.03 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.094 -1.603 . . . . 51.74 109.094 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 393' ' ' LEU . . . . . . . . . . . . . 28.2 mt -108.71 138.1 45.59 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 114.886 1.439 . . . . 43.55 114.886 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.48 123.9 27.17 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.244 -0.889 . . . . 31.91 109.86 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 395' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -115.34 149.54 37.73 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 124.372 1.045 . . . . 35.25 109.61 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 396' ' ' ILE . . . . . 0.458 HG23 ' O ' ' B' ' 362' ' ' TYR . 2.0 tt -136.34 155.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 112.367 -2.197 . . . . 41.55 106.534 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 397' ' ' THR . . . . . . . . . . . . . 28.4 p -144.07 178.12 8.09 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 121.417 1.917 . . . . 32.75 109.094 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 398' ' ' THR . . . . . . . . . . . . . 7.9 m -51.63 -31.64 26.09 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.459 0.911 . . . . 32.72 113.459 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 399' ' ' CYS . . . . . . . . . . . . . 1.6 m -92.37 -24.99 18.72 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.125 -0.943 . . . . 46.65 112.76 -176.714 -29.754 -79.2 -97.282 116.014 2.062 93.562 171.665 45.805 1 1 . 1 . 001 nuclear orig full ' B' B ' 400' ' ' SER . . . . . . . . . . . . . 72.9 m -44.52 136.09 4.43 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 119.581 -0.848 . . . . 23.74 110.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 401' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' B' ' 308' ' ' PRO . 20.3 t80 -71.08 107.01 3.93 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 124.145 0.903 . . . . 20.92 109.953 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 402' ' ' VAL . . . . . . . . . . . . . 99.2 t -135.43 117.35 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.886 -1.524 . . . . 31.76 106.886 177.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 403' ' ' ALA . . . . . . . . . . . . . . . -148.09 149.0 31.38 Favored Pre-proline 0 CA--C 1.508 -0.645 0 N-CA-C 106.566 -1.642 . . . . 40.59 106.566 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 404' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.0 135.19 42.93 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 CA-C-N 119.644 0.909 . . . . 38.73 110.613 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 405' ' ' TRP . . . . . 0.418 ' O ' ' HB2' ' B' ' 408' ' ' LEU . 75.8 t-105 -49.29 -43.41 43.21 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 122.333 1.063 . . . . 51.27 113.776 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 406' ' ' ASN . . . . . . . . . . . . 0.36 78.6 m-20 -61.16 -21.3 63.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 119.487 3.143 . . . . 53.86 119.487 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 407' ' ' SER . . . . . . . . . . . . . 93.5 p -86.75 -17.35 33.8 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.591 -1.186 . . . . 41.13 110.522 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 408' ' ' LEU . . . . . 0.418 ' HB2' ' O ' ' B' ' 405' ' ' TRP . 0.4 OUTLIER -67.8 131.62 45.88 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 115.738 1.755 . . . . 40.43 115.738 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 409' ' ' SER . . . . . . . . . . . . . 70.8 p -62.8 160.53 14.29 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.037 -1.097 . . . . 37.43 108.037 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 410' ' ' LEU . . . . . . . . . . . . . 4.2 mp -62.67 -35.14 78.72 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.92 -1.141 . . . . 41.85 107.92 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.59 13.99 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 123.949 0.78 . . . . 41.54 109.362 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 412' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -52.67 -42.04 64.37 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 123.22 0.325 . . . . 47.34 111.813 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 413' ' ' ARG . . . . . . . . . . . . . 63.5 mtt85 -58.72 -48.62 80.52 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 109.05 -0.722 . . . . 58.57 109.05 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -61.17 -34.3 74.82 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.281 -0.872 . . . . 71.04 112.625 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 415' ' ' GLY . . . . . . . . . . . . . . . -67.5 -48.06 59.27 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.233 -1.147 . . . . 29.29 110.233 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 416' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -61.73 -43.28 99.16 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.225 -0.99 . . . . 35.85 111.304 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 417' ' ' THR . . . . . . . . . . . . . 2.4 m -70.86 -37.62 73.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.932 1.456 . . . . 36.43 114.932 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 418' ' ' LYS . . . . . . . . . . . . . 11.0 tppt? -135.94 -46.09 0.65 Allowed 'General case' 0 C--N 1.35 0.63 0 N-CA-C 119.955 3.317 . . . . 63.83 119.955 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 419' ' ' THR . . . . . . . . . . . . . 5.3 p -85.39 -27.06 26.06 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 121.787 3.995 . . . . 43.94 121.787 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 420' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -58.06 -41.03 82.49 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 120.822 1.646 . . . . 27.68 114.935 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 421' ' ' THR . . . . . 0.489 HG21 ' CE1' ' B' ' 312' ' ' PHE . 1.3 p -50.02 -41.73 47.95 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 121.087 0.47 . . . . 26.92 111.434 178.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 422' ' ' VAL . . . . . . . . . . . . . 46.2 t -50.16 -34.8 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.141 -0.936 . . . . 29.04 112.933 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 423' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.21 61.72 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 118.664 -1.732 . . . . 27.23 116.264 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 424' ' ' CYS . . . . . . . . . . . . . 71.3 m -67.3 -54.57 19.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 119.491 3.145 . . . . 36.66 119.491 -174.272 -62.326 -49.168 -75.929 104.161 2.031 103.578 -66.83 -57.164 1 1 . 1 . 001 nuclear orig full ' B' B ' 425' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.43 -22.99 66.23 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 116.006 1.854 . . . . 81.49 116.006 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 114.586 1.328 . . . . 52.82 114.586 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.211 -0.94 0 N-CA-C 107.581 -1.266 . . . . 46.5 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -39.68 92.8 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.593 1.157 . . . . 74.25 113.9 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.0 m -127.01 -47.45 1.5 Allowed 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.324 0.861 . . . . 49.270000000000003 113.324 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.4 42.3 Favored Pre-proline 0 C--O 1.218 -0.583 0 N-CA-C 107.379 -1.341 . . . . 75.120000000000005 107.379 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.03 157.62 60.98 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.61 0.873 . . . . 43.640000000000001 110.871 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.48 154.19 7.53 Favored Glycine 0 C--O 1.216 -1.02 0 C-N-CA 120.34 -0.933 . . . . 36.280000000000001 112.98 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.5 pt -123.41 152.71 64.99 Favored Pre-proline 0 C--N 1.353 0.727 0 CA-C-O 119.125 -0.464 . . . . 31.129999999999999 111.806 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.51 -35.06 99.14 Favored 'Trans proline' 0 C--N 1.354 0.83 0 N-CA-C 116.308 1.619 . . . . 35.509999999999998 116.308 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -151.13 159.13 44.65 Favored 'General case' 0 C--O 1.213 -0.837 0 O-C-N 123.77 0.669 . . . . 40.670000000000002 110.209 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -74.58 130.58 39.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.178 -1.045 . . . . 36.649999999999999 108.178 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.5 mtm-85 -83.75 36.52 0.55 Allowed 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.417 1.265 . . . . 67.010000000000005 114.417 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -161.7 154.28 20.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 106.987 -1.486 . . . . 37.649999999999999 106.987 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -94.16 -30.01 14.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.215 1.191 . . . . 32.409999999999997 114.215 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HA ' ' OG1' ' A' ' 131' ' ' THR . 50.0 m-70 -95.35 99.1 11.08 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.983 -1.008 . . . . 29.52 110.397 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.08 155.3 16.81 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 122.801 1.286 . . . . 37.170000000000002 111.857 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -121.98 147.51 45.96 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 113.106 -1.861 . . . . 42.060000000000002 107.964 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -144.8 161.03 40.26 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 123.466 0.479 . . . . 45.390000000000001 111.303 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -143.27 134.5 25.9 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.884 0.698 . . . . 41.0 112.884 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mt -89.59 86.41 2.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 107.789 -1.189 . . . . 31.84 107.789 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 145' ' ' SER . 49.8 t -43.8 -62.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 116.3 1.963 . . . . 47.07 116.3 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -132.37 177.15 7.81 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.486 -0.561 . . . . 50.170000000000002 109.486 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -120.23 156.47 31.11 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.334 1.235 . . . . 50.939999999999998 114.334 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -92.12 133.61 29.97 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.407 -1.724 . . . . 54.600000000000001 109.429 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -60.22 -41.69 48.89 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 120.355 0.703 . . . . 58.5 110.596 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -31.55 -44.38 0.07 Allowed 'General case' 0 C--N 1.348 0.536 0 O-C-N 125.238 1.586 . . . . 65.730000000000004 112.799 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.2 tp -128.38 145.2 54.84 Favored Pre-proline 0 C--O 1.215 -0.747 0 N-CA-C 116.331 1.974 . . . . 57.130000000000003 116.331 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 108' ' ' LEU . 82.2 Cg_exo -56.42 130.86 42.31 Favored 'Trans proline' 0 CA--C 1.504 -0.996 0 C-N-CA 122.498 2.132 . . . . 52.25 111.285 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -37.82 -49.59 1.2 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.361 1.245 . . . . 60.359999999999999 114.361 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.0 -30.33 64.08 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.631 1.345 . . . . 66.060000000000002 114.631 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.51 -27.99 56.22 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.159 0.8 . . . . 48.740000000000002 113.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.91 -45.68 90.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 108.608 -0.886 . . . . 46.18 108.608 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.9 -40.45 73.04 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.931 -1.031 . . . . 40.219999999999999 109.913 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.5 t -63.7 -50.48 69.0 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.995 0.426 . . . . 46.590000000000003 111.122 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.66 -51.31 70.33 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 112.751 0.649 . . . . 41.770000000000003 112.751 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.26 -48.41 88.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-O 121.816 0.817 . . . . 36.840000000000003 111.96 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -45.16 84.99 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.434 -0.506 . . . . 54.090000000000003 112.327 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 196' ' ' PHE . 17.7 tptt -58.56 -38.73 78.47 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 107.381 -1.34 . . . . 45.170000000000002 107.381 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . . . -53.83 -54.91 31.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 114.695 1.369 . . . . 37.289999999999999 114.695 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 203' ' ' ILE . 85.4 mt -59.27 -39.78 83.97 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 114.249 -1.341 . . . . 29.23 113.541 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -56.58 -35.85 68.68 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.745 -0.661 . . . . 55.130000000000003 111.804 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.434 ' CG1' HD13 ' A' ' 234' ' ' LEU . 57.8 t -49.86 -38.69 14.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.494 -0.321 . . . . 38.030000000000001 111.685 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -86.72 -26.29 24.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.96 1.096 . . . . 40.810000000000002 113.96 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.37 -35.47 79.41 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.559 0.695 . . . . 58.310000000000002 112.004 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.41 -33.98 75.84 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.799 -0.637 . . . . 59.170000000000002 112.151 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 128' ' ' THR . 20.2 m -94.79 3.96 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 115.688 1.736 . . . . 41.490000000000002 115.688 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 127' ' ' VAL . 59.0 p -146.68 174.38 3.45 Favored Pre-proline 0 C--O 1.218 -0.562 0 CA-C-O 118.574 -0.727 . . . . 38.060000000000002 110.562 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 74.0 Cg_endo -86.01 14.6 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 120.861 1.041 . . . . 38.899999999999999 114.242 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 95' ' ' THR . 20.2 mt -74.07 148.89 41.48 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 113.51 0.93 . . . . 36.840000000000003 113.51 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 96' ' ' HIS . 37.9 p -130.24 147.63 51.98 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.966 1.416 . . . . 43.68 108.089 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -129.11 121.91 28.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.36 1.037 . . . . 49.060000000000002 111.543 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.5 p -112.26 125.97 54.73 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.193 -0.912 . . . . 59.950000000000003 109.595 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -80.24 142.89 34.2 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.914 -0.714 . . . . 55.049999999999997 111.55 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.98 166.33 17.13 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.986 -1.116 . . . . 42.219999999999999 107.986 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -133.91 5.79 3.64 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.58 0.956 . . . . 48.170000000000002 113.58 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.74 154.46 24.35 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.183 -1.784 . . . . 84.400000000000006 106.183 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.47 54.19 Favored Glycine 0 C--O 1.217 -0.94 0 C-N-CA 119.705 -1.236 . . . . 53.5 110.54 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -99.98 116.69 32.61 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 121.742 0.782 . . . . 64.75 110.691 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.07 176.7 6.88 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.415 -1.698 . . . . 48.659999999999997 106.415 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . 0.404 ' H ' HG23 ' A' ' 98' ' ' THR . 66.5 m-20 -69.33 -57.77 4.88 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.391 -1.337 . . . . 40.710000000000001 107.391 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 144' ' ' ILE . 78.7 mt -96.76 104.2 15.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-N 113.873 -1.512 . . . . 29.43 110.815 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 20.4 mmm -91.95 102.11 14.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.719 -1.128 . . . . 54.609999999999999 109.387 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.408 HG13 HG22 ' A' ' 142' ' ' ILE . 51.6 mt -89.84 133.25 32.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 115.492 -0.777 . . . . 38.969999999999999 110.322 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 35.2 p -159.85 156.07 26.77 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 115.842 1.793 . . . . 41.520000000000003 115.842 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -103.67 139.38 39.01 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.858 -1.065 . . . . 38.090000000000003 110.369 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 151' ' ' HIS . . . -151.51 171.57 17.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.282 -0.872 . . . . 35.450000000000003 110.279 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.88 140.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 106.939 -1.504 . . . . 40.450000000000003 106.939 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 47.05 -128.57 1.58 Allowed 'General case' 0 C--O 1.215 -0.725 0 O-C-N 123.677 0.611 . . . . 43.409999999999997 110.677 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -67.41 130.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.897 0.772 . . . . 86.590000000000003 111.057 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.523 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 41.2 p-80 -147.85 33.34 0.84 Allowed 'General case' 0 C--N 1.352 0.717 0 N-CA-C 117.608 2.447 . . . . 51.030000000000001 117.608 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.21 -64.92 0.25 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 116.113 1.205 . . . . 54.350000000000001 116.113 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -73.14 176.61 5.69 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.045 0.45 . . . . 51.740000000000002 111.186 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.24 18.44 1.74 Allowed 'General case' 0 C--N 1.348 0.508 0 N-CA-C 115.078 1.511 . . . . 55.0 115.078 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -133.54 82.3 51.96 Favored Pre-proline 0 C--O 1.218 -0.566 0 C-N-CA 119.554 -0.859 . . . . 37.590000000000003 111.656 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -62.36 147.88 94.19 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.189 1.926 . . . . 46.32 112.269 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -81.72 148.6 28.88 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.953 -1.021 . . . . 45.799999999999997 110.837 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -84.05 30.89 0.5 Allowed 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 119.488 3.144 . . . . 45.020000000000003 119.488 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.515 ' HA2' ' OD2' ' A' ' 183' ' ' ASP . . . 70.65 -165.7 52.13 Favored Glycine 0 C--O 1.218 -0.886 0 C-N-CA 117.34 -2.362 . . . . 51.0 112.722 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -62.52 141.71 87.46 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 CA-C-N 120.14 1.97 . . . . 42.899999999999999 113.954 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 82.96 -172.49 51.65 Favored Glycine 0 C--O 1.217 -0.96 0 CA-C-N 115.053 -0.976 . . . . 44.140000000000001 115.471 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 50.39 -104.54 0.16 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 113.435 -1.383 . . . . 51.460000000000001 114.605 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' B' ' 399' ' ' CYS . 57.6 t -84.22 111.14 19.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 CA-C-O 121.224 0.535 . . . . 41.200000000000003 111.102 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.48 -27.57 23.98 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 114.272 1.212 . . . . 34.630000000000003 114.272 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.412 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -172.92 163.22 4.86 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 123.893 0.746 . . . . 35.159999999999997 112.584 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -144.89 161.41 39.38 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 124.753 1.283 . . . . 36.409999999999997 110.775 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 164.46 34.63 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.849 -0.614 . . . . 27.48 112.231 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -114.71 154.43 28.48 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.802 -1.09 . . . . 41.880000000000003 113.155 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -74.01 164.36 61.72 Favored Pre-proline 0 C--O 1.206 -1.201 0 CA-C-O 117.293 -1.337 . . . . 28.07 113.948 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 89.1 Cg_exo -49.27 151.4 6.54 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 O-C-N 123.253 1.133 . . . . 25.559999999999999 112.844 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 146.98 -177.7 25.09 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 119.824 -1.179 . . . . 31.260000000000002 115.578 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.37 153.49 31.21 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.49 1.46 . . . . 41.640000000000001 114.264 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.97 -120.51 10.75 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 117.965 1.946 . . . . 40.280000000000001 117.965 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.4 tt -68.41 -12.36 15.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 112.767 0.655 . . . . 42.549999999999997 112.767 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -63.98 150.67 44.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.507 0.67 . . . . 36.899999999999999 112.366 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.17 3.13 Favored Glycine 0 C--O 1.214 -1.113 0 C-N-CA 120.06 -1.067 . . . . 28.23 114.376 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.74 158.06 25.8 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.341 0.591 . . . . 34.020000000000003 112.271 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -137.42 128.79 28.08 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.749 -1.114 . . . . 35.07 108.403 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -114.53 150.35 35.04 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.269 -0.641 . . . . 38.369999999999997 109.269 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PHE . . . . . 0.583 ' CE2' ' OE2' ' A' ' 202' ' ' GLU . 61.7 m-85 -129.35 137.45 50.98 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 124.812 1.32 . . . . 40.68 113.304 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -74.41 103.78 4.9 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.322 -0.853 . . . . 45.329999999999998 111.814 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -65.6 -26.06 67.67 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 113.934 1.087 . . . . 53.780000000000001 113.934 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.515 ' OD2' ' HA2' ' A' ' 159' ' ' GLY . 47.4 m-20 -58.6 -13.46 5.82 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 115.334 -0.848 . . . . 51.049999999999997 112.05 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -86.03 165.17 16.89 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.111 -1.07 . . . . 45.57 108.111 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -96.36 99.58 11.25 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 106.304 -1.739 . . . . 64.010000000000005 106.304 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -80.47 126.25 30.97 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.901 -1.045 . . . . 48.68 112.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 191' ' ' THR . 26.5 p -135.93 149.77 49.06 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.76 0.663 . . . . 51.420000000000002 111.024 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -90.76 8.53 34.19 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.981 -1.009 . . . . 86.480000000000004 111.102 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.18 179.34 6.38 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 120.443 -0.503 . . . . 68.590000000000003 110.978 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 227' ' ' THR . 1.5 m -78.18 51.91 1.05 Allowed 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.512 -0.767 . . . . 78.799999999999997 112.868 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 187' ' ' THR . 23.4 m -151.06 59.27 0.91 Allowed 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 108.41 -0.959 . . . . 88.969999999999999 108.41 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 147.61 -162.39 28.68 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.869 -1.692 . . . . 72.909999999999997 108.869 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 40.6 m -89.56 104.88 17.4 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 119.557 -0.857 . . . . 57.280000000000001 108.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 196' ' ' PHE . 16.5 t-20 -58.67 105.53 0.31 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.562 1.545 . . . . 53.609999999999999 113.838 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.51 -41.93 61.36 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.95 -1.023 . . . . 41.619999999999997 112.393 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PHE . . . . . 0.692 ' CE1' ' HG3' ' A' ' 119' ' ' LYS . 27.0 t80 -57.07 -57.45 12.53 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.194 0.521 . . . . 36.770000000000003 110.805 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' HG ' ' OD1' ' A' ' 194' ' ' ASN . 93.7 mt -48.23 -48.48 35.14 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 113.816 1.043 . . . . 38.229999999999997 113.816 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.517 HG13 HG21 ' B' ' 302' ' ' THR . 42.7 t -67.61 -46.41 83.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 119.401 -0.92 . . . . 36.07 112.677 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 203' ' ' ILE . . . -58.18 -43.97 87.79 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.358 -0.937 . . . . 28.52 109.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.09 71.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.243 0.545 . . . . 27.219999999999999 111.013 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -65.26 -53.41 44.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.66 -1.154 . . . . 31.699999999999999 110.194 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE2' ' CE2' ' A' ' 180' ' ' PHE . 40.3 mt-10 -59.42 -39.57 83.91 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 113.565 0.95 . . . . 29.079999999999998 113.565 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . 0.531 HG21 HD23 ' A' ' 121' ' ' LEU . 2.5 mm -59.93 -36.98 70.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-O 121.973 0.892 . . . . 35.0 108.979 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 209' ' ' LEU . . . -52.28 -35.74 43.64 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 120.329 -1.482 . . . . 26.18 110.376 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -72.76 -40.78 65.73 Favored 'General case' 0 C--O 1.214 -0.81 0 O-C-N 122.285 -0.538 . . . . 31.289999999999999 111.561 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 52.3 p -58.59 -28.7 65.83 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.656 0.598 . . . . 29.489999999999998 112.534 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.62 -12.49 42.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 114.194 1.183 . . . . 27.390000000000001 114.194 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.54 10.18 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 116.853 1.501 . . . . 26.75 116.853 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 204' ' ' GLY . 1.4 mp -87.73 159.79 18.34 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.983 0.734 . . . . 29.879999999999999 112.983 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.31 179.05 4.15 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.5 -0.773 . . . . 36.670000000000002 108.941 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' HIS . . . . . 0.779 ' HE1' ' HB3' ' B' ' 301' ' ' CYS . 44.6 m170 -71.66 145.71 48.74 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 119.318 -0.953 . . . . 29.260000000000002 110.4 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 26.9 t -104.19 155.87 18.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.544 -1.207 . . . . 35.159999999999997 109.613 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.89 -24.47 17.71 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.762 -1.108 . . . . 47.390000000000001 108.285 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.36 111.6 2.71 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.626 -1.25 . . . . 50.719999999999999 107.626 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 220' ' ' TYR . 37.8 p -59.61 -24.47 63.83 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 114.512 1.301 . . . . 47.399999999999999 114.512 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -13.74 56.75 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.973 0.796 . . . . 67.680000000000007 112.75 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.75 134.9 37.02 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.94 0.718 . . . . 42.189999999999998 112.94 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.75 -41.04 63.65 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.083 0.468 . . . . 35.840000000000003 110.43 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 80.2 mmm -66.51 4.49 0.75 Allowed 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 115.277 1.584 . . . . 40.82 115.277 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' A' ' 215' ' ' THR . 59.5 t80 -72.59 127.67 89.58 Favored Pre-proline 0 C--O 1.217 -0.619 0 N-CA-C 103.469 -2.789 . . . . 36.390000000000001 103.469 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.36 -30.69 29.67 Favored 'Trans proline' 0 C--O 1.202 -1.309 0 N-CA-C 117.511 2.081 . . . . 31.289999999999999 117.511 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' B' ' 303' ' ' CYS . 3.3 mt -71.44 111.17 6.54 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 121.245 -0.909 . . . . 34.609999999999999 112.633 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -57.12 105.66 0.25 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.689 0.795 . . . . 51.640000000000001 112.451 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -96.53 13.93 26.41 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 117.693 2.479 . . . . 79.150000000000006 117.693 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.0 p 15.4 105.45 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 120.426 3.491 . . . . 69.129999999999995 120.426 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 145.15 25.12 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-O 121.376 0.608 . . . . 76.420000000000002 112.597 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' HG21 ' A' ' 190' ' ' THR . 5.3 m -54.55 -85.91 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 116.327 1.973 . . . . 87.390000000000001 116.327 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.55 113.9 18.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.284 -1.51 . . . . 85.170000000000002 109.511 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -34.94 79.26 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 113.241 0.83 . . . . 79.349999999999994 113.241 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.5 m -50.67 -35.18 29.59 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 115.339 1.607 . . . . 91.150000000000006 115.339 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -95.63 28.52 2.97 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.808 1.41 . . . . 89.329999999999998 114.808 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -67.2 138.15 56.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.63 -0.507 . . . . 78.879999999999995 109.63 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.89 146.61 34.23 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.627 -0.715 . . . . 85.069999999999993 110.511 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 239' ' ' ILE . 6.3 tp -80.99 146.03 30.89 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.394 -0.821 . . . . 55.609999999999999 109.119 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.9 t -78.5 142.68 37.26 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.339 -1.345 . . . . 51.729999999999997 107.564 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -46.45 -47.96 19.02 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.698 -1.593 . . . . 46.32 106.698 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -46.95 -41.28 15.87 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.76 1.393 . . . . 50.840000000000003 114.76 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -68.69 -37.22 79.39 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.865 -0.734 . . . . 29.489999999999998 109.61 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ILE . . . . . 0.484 HG12 HD23 ' A' ' 234' ' ' LEU . 61.3 mt -63.4 -52.07 62.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.522 -0.763 . . . . 27.5 109.27 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -57.25 -34.83 69.01 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.01 -0.737 . . . . 34.450000000000003 109.01 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -66.64 -56.18 14.29 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 120.97 -0.633 . . . . 28.940000000000001 114.331 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 242' ' ' ILE . 10.1 tp -67.16 -35.99 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 114.134 1.161 . . . . 30.41 114.134 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.2 -31.58 66.01 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.787 -0.765 . . . . 43.409999999999997 112.946 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.4 p -62.49 -7.17 4.13 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.703 0.763 . . . . 35.100000000000001 112.164 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tp -108.91 -62.02 1.53 Allowed 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.5 -0.926 . . . . 33.030000000000001 108.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -99.48 4.8 46.22 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 116.975 2.213 . . . . 34.640000000000001 116.975 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 71.41 167.31 8.12 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.548 -1.14 . . . . 34.719999999999999 112.392 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.58 171.12 8.73 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.421 1.61 . . . . 38.659999999999997 111.245 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -65.83 143.69 74.44 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 119.226 0.759 . . . . 49.600000000000001 111.555 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 129' ' ' PRO . 50.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 C-N-CA 124.092 3.195 . . . . 55.170000000000002 114.452 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' CYS . . . . . 0.779 ' HB3' ' HE1' ' A' ' 211' ' ' HIS . 42.6 t . . . . . 0 CA--C 1.501 -0.934 0 CA-C-O 121.607 0.717 . . . . 30.800000000000001 110.081 . -175.675 113.366 99.563 100.296 2.057 100.774 -68.107 -43.833 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' THR . . . . . 0.517 HG21 HG13 ' A' ' 198' ' ' VAL . 14.1 t -129.21 147.63 51.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.595 -2.002 . . . . 30.079999999999998 105.595 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 222' ' ' LEU . 4.3 p -167.13 159.74 13.25 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 118.596 2.813 . . . . 44.0 118.596 -179.23 45.805 171.665 -97.282 93.562 2.062 116.014 -79.2 -29.754 2 2 . 1 . 001 nuclear build full ' B' B ' 304' ' ' VAL . . . . . 0.526 ' O ' HG13 ' B' ' 304' ' ' VAL . 8.0 p -100.26 115.77 65.13 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 105.709 -1.959 . . . . 32.829999999999998 105.709 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 304' ' ' VAL . 32.2 Cg_endo -64.24 162.11 31.39 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 120.487 0.791 . . . . 39.450000000000003 113.069 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.82 159.48 4.1 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 N-CA-C 109.548 -0.982 . . . . 36.369999999999997 109.548 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -70.52 149.96 95.58 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 103.195 -2.891 . . . . 34.840000000000003 103.195 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' PRO . . . . . 0.419 ' HG3' ' CE2' ' B' ' 401' ' ' PHE . 46.4 Cg_exo -51.08 -40.23 59.75 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 O-C-N 116.59 -2.374 . . . . 27.899999999999999 115.012 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 309' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.13 -48.02 83.47 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.939 -0.704 . . . . 30.489999999999998 112.503 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -34.63 77.93 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.602 -0.839 . . . . 29.09 109.144 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' ALA . . . . . . . . . . . . . . . -59.28 -42.08 90.44 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.324 -0.621 . . . . 25.039999999999999 109.324 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.84 -46.89 61.89 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.032 0.753 . . . . 30.129999999999999 113.032 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' CYS . . . . . . . . . . . . . 63.7 m -65.88 -50.5 64.27 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 114.496 1.295 . . . . 32.619999999999997 114.496 -177.264 -57.164 -66.83 -75.929 103.578 2.031 104.161 -49.168 -62.326 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -76.11 -15.13 60.15 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 116.593 2.071 . . . . 35.090000000000003 116.593 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' SER . . . . . . . . . . . . . 74.9 m -75.94 163.12 27.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.379 -0.929 . . . . 29.75 110.065 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.44 -35.39 11.73 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.518 -0.765 . . . . 37.979999999999997 109.695 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' LEU . . . . . 0.458 HD23 HD13 ' B' ' 319' ' ' ILE . 8.2 mp -135.46 139.92 44.46 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.623 -0.88 . . . . 32.719999999999999 108.623 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.66 89.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 102.441 -3.17 . . . . 34.350000000000001 102.441 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ILE . . . . . 0.485 HD12 ' HG3' ' B' ' 345' ' ' MET . 1.0 OUTLIER -95.15 166.58 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 111.524 -2.58 . . . . 42.68 111.342 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -127.14 130.91 50.69 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 101.423 -3.547 . . . . 39.880000000000003 101.423 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.0 176.95 11.25 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 114.229 1.196 . . . . 34.710000000000001 114.229 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -121.23 144.46 48.6 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 107.506 -1.294 . . . . 45.619999999999997 107.506 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -82.66 109.93 17.27 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 44.219999999999999 110.721 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.28 -35.84 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 124.655 1.222 . . . . 53.289999999999999 114.278 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . -134.99 160.3 24.27 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 118.658 -1.734 . . . . 49.609999999999999 115.617 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' THR . . . . . 0.537 HG22 ' HD2' ' B' ' 327' ' ' PRO . 0.0 OUTLIER -72.84 153.65 91.16 Favored Pre-proline 0 C--O 1.218 -0.586 0 CA-C-N 114.112 -1.044 . . . . 46.399999999999999 110.467 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 327' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' B' ' 326' ' ' THR . 17.7 Cg_endo -56.81 136.01 73.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 N-CA-C 117.617 2.122 . . . . 44.329999999999998 117.617 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.3 138.38 29.49 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 114.077 -1.42 . . . . 65.849999999999994 109.322 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 329' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 332' ' ' THR . 5.2 t -74.91 114.81 15.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.531 -0.914 . . . . 56.130000000000003 108.531 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' ASN . . . . . 0.898 ' HB2' ' HD3' ' B' ' 337' ' ' ARG . 26.5 t-20 -74.0 -111.56 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 O-C-N 123.859 0.724 . . . . 53.100000000000001 112.762 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLN . . . . . 0.676 ' N ' ' OD1' ' B' ' 330' ' ' ASN . 2.4 pt20 -104.92 25.15 10.83 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.497 -0.752 . . . . 58.240000000000002 110.716 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 332' ' ' THR . . . . . 0.779 HG22 ' H ' ' B' ' 334' ' ' LEU . 47.5 m -156.0 136.29 13.04 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 118.636 -0.697 . . . . 50.460000000000001 109.783 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' THR . . . . . . . . . . . . . 71.7 m -69.92 -23.47 63.23 Favored 'General case' 0 C--O 1.207 -1.173 0 O-C-N 124.091 0.869 . . . . 54.229999999999997 112.761 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' LEU . . . . . 0.779 ' H ' HG22 ' B' ' 332' ' ' THR . 18.9 mt -70.37 -32.58 70.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 116.285 1.957 . . . . 40.93 116.285 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 335' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.99 146.55 49.36 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 119.591 -0.844 . . . . 39.280000000000001 110.469 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 336' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -110.69 148.04 33.11 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.006 -2.59 . . . . 60.939999999999998 104.006 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' ARG . . . . . 0.898 ' HD3' ' HB2' ' B' ' 330' ' ' ASN . 25.9 ptt180 -128.85 149.31 50.81 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 118.937 -1.105 . . . . 47.850000000000001 113.606 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 338' ' ' TYR . . . . . 0.464 ' HB2' ' CG1' ' B' ' 361' ' ' VAL . 46.7 m-85 -111.83 133.73 53.85 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 124.736 1.273 . . . . 51.43 108.231 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.78 131.36 37.57 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 104.412 -2.44 . . . . 63.189999999999998 104.412 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.4 149.5 33.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 123.83 0.706 . . . . 44.140000000000001 112.364 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -106.68 100.43 9.95 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.893 -1.049 . . . . 73.269999999999996 108.973 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 3.7 ttp -73.94 119.14 17.74 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 117.481 2.4 . . . . 47.109999999999999 117.481 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' THR . . . . . . . . . . . . . 66.9 p -95.06 -77.82 0.46 Allowed 'General case' 0 C--O 1.216 -0.695 0 O-C-N 123.57 0.544 . . . . 46.759999999999998 110.983 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 141.89 35.12 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 118.677 -0.678 . . . . 66.840000000000003 111.156 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' MET . . . . . 0.485 ' HG3' HD12 ' B' ' 319' ' ' ILE . 6.6 ttm -117.59 110.35 17.81 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.586 -0.524 . . . . 36.200000000000003 109.586 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -85.28 -17.65 36.3 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.047 1.499 . . . . 44.049999999999997 115.047 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -157.81 151.3 23.62 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 120.423 -0.511 . . . . 32.990000000000002 112.318 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . 103.72 29.93 5.4 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.14 -0.936 . . . . 43.32 113.655 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 349' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.15 -3.19 2.52 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 114.454 1.279 . . . . 57.020000000000003 114.454 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.65 37.51 0.88 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 123.558 1.647 . . . . 82.340000000000003 108.687 170.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -163.37 8.89 0.05 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 126.601 1.961 . . . . 84.409999999999997 112.129 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 352' ' ' LEU . . . . . . . . . . . . 0.25 3.6 mm? 51.84 -106.22 0.26 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 116.062 1.875 . . . . 98.310000000000002 116.062 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 353' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 355' ' ' ALA . . . 100.22 -44.03 1.68 Allowed Glycine 1 N--CA 1.538 5.444 3 C-N-CA 110.885 -5.436 . . . . 89.799999999999997 125.273 -176.214 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' B' B ' 354' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 25.66 -66.65 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.672 1 CA-C-N 107.992 -4.104 . . . . 96.530000000000001 120.134 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 355' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 353' ' ' GLY . . . -157.51 -6.14 0.09 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.139 1.375 . . . . 77.390000000000001 111.325 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -168.05 45.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 114.378 1.251 . . . . 64.780000000000001 114.378 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' ASP . . . . . 0.517 ' HB3' ' HA2' ' B' ' 353' ' ' GLY . 22.6 t0 -104.92 -32.76 8.62 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 118.929 -1.108 . . . . 72.409999999999997 109.152 171.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 358' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.92 108.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 101.709 -3.441 . . . . 60.689999999999998 101.709 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -119.56 3.99 11.16 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.956 0.785 . . . . 83.620000000000005 112.912 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.93 137.18 26.01 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.392 -0.367 . . . . 58.060000000000002 111.21 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 338' ' ' TYR . 5.9 p -115.64 124.56 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 N-CA-C 106.135 -1.802 . . . . 35.979999999999997 106.135 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 362' ' ' TYR . . . . . 0.499 ' O ' HG22 ' B' ' 396' ' ' ILE . 6.0 m-85 -98.41 158.26 15.69 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.612 -0.722 . . . . 49.200000000000003 112.155 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 363' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' B' ' 396' ' ' ILE . 14.6 t -161.3 155.56 19.25 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.125 -1.805 . . . . 29.050000000000001 106.125 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 364' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.27 157.23 4.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 N-CA-C 115.858 1.445 . . . . 35.289999999999999 115.858 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.75 75.63 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 119.698 3.221 . . . . 36.609999999999999 119.698 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' MET . . . . . . . . . . . . . 13.7 ptm -131.99 139.88 48.78 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.284 -1.325 . . . . 47.920000000000002 113.523 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -49.84 -48.36 51.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.287 -0.87 . . . . 26.579999999999998 112.003 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' SER . . . . . . . . . . . . . 54.5 p -48.05 -32.69 7.01 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.817 0.673 . . . . 28.949999999999999 112.817 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 369' ' ' VAL . 0.3 OUTLIER -104.92 27.0 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 113.887 1.069 . . . . 29.93 113.887 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 370' ' ' CYS . . . . . . . . . . . . 0.337 7.9 m 91.94 6.81 0.06 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 121.52 3.896 . . . . 35.82 121.52 174.646 -43.833 -68.107 99.563 100.774 2.057 100.296 113.366 -175.675 2 2 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLY . . . . . . . . . . . . . . . -61.32 139.8 47.53 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 119.766 -1.207 . . . . 31.52 111.337 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 372' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -84.39 140.32 31.64 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 117.464 0.632 . . . . 39.890000000000001 111.157 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -119.92 107.71 13.46 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.285 1.587 . . . . 42.520000000000003 115.285 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.07 124.45 41.08 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 115.445 1.646 . . . . 49.329999999999998 115.445 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 74.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.582 1.697 . . . . 76.829999999999998 115.582 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 12.6 m -111.18 152.05 27.5 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 121.345 -0.847 . . . . 79.909999999999997 110.081 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 377' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 -38.6 32.91 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.473 1.909 . . . . 93.969999999999999 116.018 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 378' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -103.76 114.44 28.71 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 122.852 0.461 . . . . 82.609999999999999 110.085 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -69.92 -19.98 63.37 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 117.769 2.507 . . . . 95.150000000000006 117.769 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' SER . . . . . . . . . . . . . 58.0 m -78.95 -5.09 52.89 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 113.37 0.878 . . . . 84.090000000000003 113.37 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -63.07 143.05 58.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.826 -0.624 . . . . 71.340000000000003 110.697 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.97 141.05 37.25 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 115.023 1.49 . . . . 60.789999999999999 115.023 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.61 156.89 33.33 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 113.541 -1.663 . . . . 45.219999999999999 114.394 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -108.08 112.79 25.51 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 103.378 -2.823 . . . . 35.219999999999999 103.378 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.25 119.17 59.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 106.632 -1.618 . . . . 22.07 106.632 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 386' ' ' ALA . . . . . . . . . . . . . . . -107.6 112.94 25.91 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.584 -2.006 . . . . 23.960000000000001 105.584 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 387' ' ' GLY . . . . . . . . . . . . . . . -136.42 171.8 22.73 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 118.439 -1.839 . . . . 24.77 116.088 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 388' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -99.46 169.41 9.34 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 114.399 -0.901 . . . . 36.060000000000002 110.288 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 389' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.8 99.46 6.54 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.425 -0.51 . . . . 47.219999999999999 109.786 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 390' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 391' ' ' ASP . 38.6 tt0 -89.29 125.19 35.01 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 102.127 -3.286 . . . . 65.609999999999999 102.127 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 391' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 390' ' ' GLN . 38.1 m-20 65.01 -126.42 0.37 Allowed 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 103.451 -2.796 . . . . 72.939999999999998 103.451 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . -115.6 21.04 13.03 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.094 -1.603 . . . . 51.740000000000002 109.094 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 393' ' ' LEU . . . . . . . . . . . . . 28.2 mt -108.71 138.1 45.59 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 114.886 1.439 . . . . 43.549999999999997 114.886 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.48 123.9 27.17 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.244 -0.889 . . . . 31.91 109.86 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 395' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -115.34 149.54 37.73 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 124.372 1.045 . . . . 35.25 109.61 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 396' ' ' ILE . . . . . 0.702 HD11 HG21 ' B' ' 402' ' ' VAL . 2.0 tt -136.34 155.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 112.367 -2.197 . . . . 41.549999999999997 106.534 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 397' ' ' THR . . . . . . . . . . . . . 28.4 p -144.07 178.12 8.09 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 121.417 1.917 . . . . 32.75 109.094 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 398' ' ' THR . . . . . . . . . . . . . 7.9 m -51.63 -31.64 26.09 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.459 0.911 . . . . 32.719999999999999 113.459 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 399' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.6 m -92.37 -24.99 18.72 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.125 -0.943 . . . . 46.649999999999999 112.76 -176.714 -29.754 -79.2 -97.282 116.014 2.062 93.562 171.665 45.805 2 2 . 1 . 001 nuclear build full ' B' B ' 400' ' ' SER . . . . . . . . . . . . . 72.9 m -44.52 136.09 4.43 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 119.581 -0.848 . . . . 23.739999999999998 110.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 401' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' B' ' 308' ' ' PRO . 20.3 t80 -71.08 107.01 3.93 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 124.145 0.903 . . . . 20.920000000000002 109.953 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 402' ' ' VAL . . . . . 0.702 HG21 HD11 ' B' ' 396' ' ' ILE . 99.2 t -135.43 117.35 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.886 -1.524 . . . . 31.760000000000002 106.886 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 403' ' ' ALA . . . . . . . . . . . . . . . -148.09 149.0 31.38 Favored Pre-proline 0 CA--C 1.508 -0.645 0 N-CA-C 106.566 -1.642 . . . . 40.590000000000003 106.566 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 404' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.0 135.19 42.93 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 CA-C-N 119.644 0.909 . . . . 38.729999999999997 110.613 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 405' ' ' TRP . . . . . 0.439 ' O ' ' HB2' ' B' ' 408' ' ' LEU . 75.8 t-105 -49.29 -43.41 43.21 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 122.333 1.063 . . . . 51.270000000000003 113.776 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 406' ' ' ASN . . . . . 0.406 ' HA ' HH21 ' B' ' 413' ' ' ARG 0.36 78.6 m-20 -61.16 -21.3 63.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 119.487 3.143 . . . . 53.859999999999999 119.487 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 407' ' ' SER . . . . . . . . . . . . . 93.5 p -86.75 -17.35 33.8 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.591 -1.186 . . . . 41.130000000000003 110.522 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 408' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 405' ' ' TRP . 0.4 OUTLIER -67.8 131.62 45.88 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 115.738 1.755 . . . . 40.43 115.738 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 409' ' ' SER . . . . . . . . . . . . . 70.8 p -62.8 160.53 14.29 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.037 -1.097 . . . . 37.43 108.037 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 410' ' ' LEU . . . . . 0.721 ' H ' HD12 ' B' ' 410' ' ' LEU . 4.2 mp -62.67 -35.14 78.72 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.92 -1.141 . . . . 41.850000000000001 107.92 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.59 13.99 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 123.949 0.78 . . . . 41.539999999999999 109.362 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 412' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -52.67 -42.04 64.37 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 123.22 0.325 . . . . 47.340000000000003 111.813 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 413' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 406' ' ' ASN . 63.5 mtt85 -58.72 -48.62 80.52 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 109.05 -0.722 . . . . 58.57 109.05 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -61.17 -34.3 74.82 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.281 -0.872 . . . . 71.040000000000006 112.625 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 415' ' ' GLY . . . . . . . . . . . . . . . -67.5 -48.06 59.27 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.233 -1.147 . . . . 29.289999999999999 110.233 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 416' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -61.73 -43.28 99.16 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.225 -0.99 . . . . 35.850000000000001 111.304 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 417' ' ' THR . . . . . . . . . . . . . 2.4 m -70.86 -37.62 73.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.932 1.456 . . . . 36.43 114.932 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 418' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' B' ' 418' ' ' LYS . 11.0 tppt? -135.94 -46.09 0.65 Allowed 'General case' 0 C--N 1.35 0.63 0 N-CA-C 119.955 3.317 . . . . 63.829999999999998 119.955 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 419' ' ' THR . . . . . . . . . . . . . 5.3 p -85.39 -27.06 26.06 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 121.787 3.995 . . . . 43.939999999999998 121.787 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 420' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -58.06 -41.03 82.49 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 120.822 1.646 . . . . 27.68 114.935 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 421' ' ' THR . . . . . . . . . . . . . 1.3 p -50.02 -41.73 47.95 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 121.087 0.47 . . . . 26.920000000000002 111.434 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 422' ' ' VAL . . . . . . . . . . . . . 46.2 t -50.16 -34.8 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.141 -0.936 . . . . 29.039999999999999 112.933 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 423' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.21 61.72 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 118.664 -1.732 . . . . 27.23 116.264 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 424' ' ' CYS . . . . . . . . . . . . . 71.3 m -67.3 -54.57 19.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 119.491 3.145 . . . . 36.659999999999997 119.491 -174.272 -62.326 -49.168 -75.929 104.161 2.031 103.578 -66.83 -57.164 1 1 . 1 . 001 nuclear build full ' B' B ' 425' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.43 -22.99 66.23 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 116.006 1.854 . . . . 81.489999999999995 116.006 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 114.586 1.328 . . . . 52.82 114.586 -174.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.211 -0.94 0 N-CA-C 107.581 -1.266 . . . . 46.5 107.581 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -65.31 -39.68 92.8 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 124.593 1.157 . . . . 74.25 113.9 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.0 m -127.01 -47.45 1.5 Allowed 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.324 0.861 . . . . 49.27 113.324 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.38 148.4 42.3 Favored Pre-proline 0 C--O 1.218 -0.583 0 N-CA-C 107.379 -1.341 . . . . 75.12 107.379 175.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -68.03 157.62 60.98 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 120.61 0.873 . . . . 43.64 110.871 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 132.48 154.19 7.53 Favored Glycine 0 C--O 1.216 -1.02 0 C-N-CA 120.34 -0.933 . . . . 36.28 112.98 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 39.5 pt -123.41 152.71 64.99 Favored Pre-proline 0 C--N 1.353 0.727 0 CA-C-O 119.125 -0.464 . . . . 31.13 111.806 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.51 -35.06 99.14 Favored 'Trans proline' 0 C--N 1.354 0.83 0 N-CA-C 116.308 1.619 . . . . 35.51 116.308 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.8 ptmt -151.13 159.13 44.65 Favored 'General case' 0 C--O 1.213 -0.837 0 O-C-N 123.77 0.669 . . . . 40.67 110.209 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -74.58 130.58 39.82 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 108.178 -1.045 . . . . 36.65 108.178 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.5 mtm-85 -83.75 36.52 0.55 Allowed 'General case' 0 C--O 1.219 -0.541 0 N-CA-C 114.417 1.265 . . . . 67.01 114.417 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -161.7 154.28 20.13 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 106.987 -1.486 . . . . 37.65 106.987 178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.499 HG22 ' HA ' ' A' ' 130' ' ' LEU . 0.2 OUTLIER -94.16 -30.01 14.84 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 114.215 1.191 . . . . 32.41 114.215 -177.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.412 ' HA ' ' OG1' ' A' ' 131' ' ' THR . 50.0 m-70 -95.35 99.1 11.08 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.983 -1.008 . . . . 29.52 110.397 -176.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.08 155.3 16.81 Favored 'General case' 0 C--O 1.206 -1.206 0 CA-C-O 122.801 1.286 . . . . 37.17 111.857 179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 141' ' ' ASP . 0.1 OUTLIER -121.98 147.51 45.96 Favored 'General case' 0 C--O 1.215 -0.712 0 CA-C-N 113.106 -1.861 . . . . 42.06 107.964 179.351 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 34.9 p90 -144.8 161.03 40.26 Favored 'General case' 0 C--O 1.218 -0.575 0 O-C-N 123.466 0.479 . . . . 45.39 111.303 -178.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.0 ttp85 -143.27 134.5 25.9 Favored 'General case' 0 C--O 1.216 -0.659 0 N-CA-C 112.884 0.698 . . . . 41.0 112.884 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 13.3 mt -89.59 86.41 2.58 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 N-CA-C 107.789 -1.189 . . . . 31.84 107.789 175.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.527 ' HB ' ' HB3' ' A' ' 145' ' ' SER . 49.8 t -43.8 -62.43 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 116.3 1.963 . . . . 47.07 116.3 -175.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 33.1 p30 -132.37 177.15 7.81 Favored 'General case' 0 C--O 1.218 -0.599 0 N-CA-C 109.486 -0.561 . . . . 50.17 109.486 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 48.1 m-85 -120.23 156.47 31.11 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.334 1.235 . . . . 50.94 114.334 -177.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.7 t -92.12 133.61 29.97 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 113.407 -1.724 . . . . 54.6 109.429 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_exo -60.22 -41.69 48.89 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 120.355 0.703 . . . . 58.5 110.596 176.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -31.55 -44.38 0.07 Allowed 'General case' 0 C--N 1.348 0.536 0 O-C-N 125.238 1.586 . . . . 65.73 112.799 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 109' ' ' PRO . 1.2 tp -128.38 145.2 54.84 Favored Pre-proline 0 C--O 1.215 -0.747 0 N-CA-C 116.331 1.974 . . . . 57.13 116.331 -176.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 108' ' ' LEU . 82.2 Cg_exo -56.42 130.86 42.31 Favored 'Trans proline' 0 CA--C 1.504 -0.996 0 C-N-CA 122.498 2.132 . . . . 52.25 111.285 178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -37.82 -49.59 1.2 Allowed 'General case' 0 C--O 1.215 -0.729 0 N-CA-C 114.361 1.245 . . . . 60.36 114.361 -179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -57.0 -30.33 64.08 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.631 1.345 . . . . 66.06 114.631 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -76.51 -27.99 56.22 Favored 'General case' 0 C--O 1.218 -0.559 0 N-CA-C 113.159 0.8 . . . . 48.74 113.159 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.91 -45.68 90.52 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.721 0 N-CA-C 108.608 -0.886 . . . . 46.18 108.608 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -55.9 -40.45 73.04 Favored 'General case' 0 C--O 1.209 -1.038 0 CA-C-N 114.931 -1.031 . . . . 40.22 109.913 178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' SER . . . . . . . . . . . . . 42.5 t -63.7 -50.48 69.0 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-O 120.995 0.426 . . . . 46.59 111.122 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -59.66 -51.31 70.33 Favored 'General case' 0 C--O 1.216 -0.669 0 N-CA-C 112.751 0.649 . . . . 41.77 112.751 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 85.4 t -60.26 -48.41 88.27 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.784 0 CA-C-O 121.816 0.817 . . . . 36.84 111.96 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.42 -45.16 84.99 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.434 -0.506 . . . . 54.09 112.327 -178.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.692 ' HG3' ' CE1' ' A' ' 196' ' ' PHE . 17.7 tptt -58.56 -38.73 78.47 Favored 'General case' 0 C--O 1.214 -0.799 0 N-CA-C 107.381 -1.34 . . . . 45.17 107.381 177.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 196' ' ' PHE . . . -53.83 -54.91 31.86 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 114.695 1.369 . . . . 37.29 114.695 177.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.531 HD23 HG21 ' A' ' 203' ' ' ILE . 85.4 mt -59.27 -39.78 83.97 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 114.249 -1.341 . . . . 29.23 113.541 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 41.2 tttm -56.58 -35.85 68.68 Favored 'General case' 0 C--O 1.212 -0.921 0 CA-C-N 115.745 -0.661 . . . . 55.13 111.804 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.434 ' CG1' HD13 ' A' ' 234' ' ' LEU . 57.8 t -49.86 -38.69 14.26 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.494 -0.321 . . . . 38.03 111.685 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -86.72 -26.29 24.3 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.96 1.096 . . . . 40.81 113.96 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -67.37 -35.47 79.41 Favored 'General case' 0 C--O 1.217 -0.629 0 CA-C-O 121.559 0.695 . . . . 58.31 112.004 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -62.41 -33.98 75.84 Favored 'General case' 0 C--O 1.219 -0.522 0 CA-C-N 115.799 -0.637 . . . . 59.17 112.151 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.56 HG23 HG23 ' A' ' 128' ' ' THR . 20.2 m -94.79 3.96 8.77 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.434 0 N-CA-C 115.688 1.736 . . . . 41.49 115.688 -177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.56 HG23 HG23 ' A' ' 127' ' ' VAL . 59.0 p -146.68 174.38 3.45 Favored Pre-proline 0 C--O 1.218 -0.562 0 CA-C-O 118.574 -0.727 . . . . 38.06 110.562 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 128' ' ' THR . 74.0 Cg_endo -86.01 14.6 2.41 Favored 'Trans proline' 0 CA--C 1.504 -1.016 0 C-N-CA 120.861 1.041 . . . . 38.9 114.242 174.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.499 ' HA ' HG22 ' A' ' 95' ' ' THR . 20.2 mt -74.07 148.89 41.48 Favored 'General case' 0 C--O 1.214 -0.771 0 N-CA-C 113.51 0.93 . . . . 36.84 113.51 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . 0.412 ' OG1' ' HA ' ' A' ' 96' ' ' HIS . 37.9 p -130.24 147.63 51.98 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 124.966 1.416 . . . . 43.68 108.089 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -129.11 121.91 28.79 Favored 'General case' 0 C--O 1.216 -0.671 0 O-C-N 124.36 1.037 . . . . 49.06 111.543 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 5.5 p -112.26 125.97 54.73 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 115.193 -0.912 . . . . 59.95 109.595 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -80.24 142.89 34.2 Favored 'General case' 0 C--O 1.218 -0.598 0 C-N-CA 119.914 -0.714 . . . . 55.05 111.55 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.98 166.33 17.13 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 107.986 -1.116 . . . . 42.22 107.986 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -133.91 5.79 3.64 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 113.58 0.956 . . . . 48.17 113.58 179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -159.74 154.46 24.35 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 106.183 -1.784 . . . . 84.4 106.183 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.47 54.19 Favored Glycine 0 C--O 1.217 -0.94 0 C-N-CA 119.705 -1.236 . . . . 53.5 110.54 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -99.98 116.69 32.61 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-O 121.742 0.782 . . . . 64.75 110.691 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -89.07 176.7 6.88 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 106.415 -1.698 . . . . 48.66 106.415 175.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . 0.404 ' H ' HG23 ' A' ' 98' ' ' THR . 66.5 m-20 -69.33 -57.77 4.88 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 107.391 -1.337 . . . . 40.71 107.391 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . 0.408 HG22 HG13 ' A' ' 144' ' ' ILE . 78.7 mt -96.76 104.2 15.58 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.59 0 CA-C-N 113.873 -1.512 . . . . 29.43 110.815 -177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 20.4 mmm -91.95 102.11 14.68 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 114.719 -1.128 . . . . 54.61 109.387 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.408 HG13 HG22 ' A' ' 142' ' ' ILE . 51.6 mt -89.84 133.25 32.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.586 0 CA-C-N 115.492 -0.777 . . . . 38.97 110.322 179.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' ' HB ' ' A' ' 102' ' ' VAL . 35.2 p -159.85 156.07 26.77 Favored 'General case' 0 C--O 1.212 -0.912 0 N-CA-C 115.842 1.793 . . . . 41.52 115.842 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -103.67 139.38 39.01 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 114.858 -1.065 . . . . 38.09 110.369 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 151' ' ' HIS . . . -151.51 171.57 17.36 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 115.282 -0.872 . . . . 35.45 110.279 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 51.2 t -138.88 140.5 38.66 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.561 0 N-CA-C 106.939 -1.504 . . . . 40.45 106.939 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 40.1 mmt180 47.05 -128.57 1.58 Allowed 'General case' 0 C--O 1.215 -0.725 0 O-C-N 123.677 0.611 . . . . 43.41 110.677 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 29.0 tp10 -67.41 130.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 118.897 0.772 . . . . 86.59 111.057 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.523 ' HB3' ' HB1' ' A' ' 147' ' ' ALA . 41.2 p-80 -147.85 33.34 0.84 Allowed 'General case' 0 C--N 1.352 0.717 0 N-CA-C 117.608 2.447 . . . . 51.03 117.608 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 108.21 -64.92 0.25 Allowed Glycine 0 C--N 1.345 1.035 0 N-CA-C 116.113 1.205 . . . . 54.35 116.113 177.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -73.14 176.61 5.69 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.045 0.45 . . . . 51.74 111.186 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -83.24 18.44 1.74 Allowed 'General case' 0 C--N 1.348 0.508 0 N-CA-C 115.078 1.511 . . . . 55.0 115.078 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -133.54 82.3 51.96 Favored Pre-proline 0 C--O 1.218 -0.566 0 C-N-CA 119.554 -0.859 . . . . 37.59 111.656 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -62.36 147.88 94.19 Favored 'Trans proline' 0 CA--C 1.502 -1.081 0 C-N-CA 122.189 1.926 . . . . 46.32 112.269 178.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -81.72 148.6 28.88 Favored 'General case' 0 C--O 1.213 -0.868 0 CA-C-N 114.953 -1.021 . . . . 45.8 110.837 -178.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 42.0 p30 -84.05 30.89 0.5 Allowed 'General case' 0 C--O 1.221 -0.435 0 N-CA-C 119.488 3.144 . . . . 45.02 119.488 -175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.515 ' HA2' ' OD2' ' A' ' 183' ' ' ASP . . . 70.65 -165.7 52.13 Favored Glycine 0 C--O 1.218 -0.886 0 C-N-CA 117.34 -2.362 . . . . 51.0 112.722 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -62.52 141.71 87.46 Favored 'Trans proline' 0 CA--C 1.505 -0.97 0 CA-C-N 120.14 1.97 . . . . 42.9 113.954 177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 82.96 -172.49 51.65 Favored Glycine 0 C--O 1.217 -0.96 0 CA-C-N 115.053 -0.976 . . . . 44.14 115.471 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 50.39 -104.54 0.16 Allowed 'General case' 0 C--O 1.215 -0.759 0 CA-C-N 113.435 -1.383 . . . . 51.46 114.605 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.461 HG22 ' SG ' ' B' ' 399' ' ' CYS . 57.6 t -84.22 111.14 19.65 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.701 0 CA-C-O 121.224 0.535 . . . . 41.2 111.102 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.48 -27.57 23.98 Favored 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 114.272 1.212 . . . . 34.63 114.272 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.412 ' HB1' ' CD ' ' A' ' 202' ' ' GLU . . . -172.92 163.22 4.86 Favored 'General case' 0 C--O 1.218 -0.579 0 O-C-N 123.893 0.746 . . . . 35.16 112.584 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.5 p80 -144.89 161.41 39.38 Favored 'General case' 0 C--O 1.218 -0.583 0 O-C-N 124.753 1.283 . . . . 36.41 110.775 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 164.46 34.63 Favored 'General case' 0 C--O 1.215 -0.725 0 CA-C-N 115.849 -0.614 . . . . 27.48 112.231 -177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -114.71 154.43 28.48 Favored 'General case' 0 C--O 1.209 -1.077 0 CA-C-N 114.802 -1.09 . . . . 41.88 113.155 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.454 ' HB1' ' HD2' ' A' ' 170' ' ' PRO . . . -74.01 164.36 61.72 Favored Pre-proline 0 C--O 1.206 -1.201 0 CA-C-O 117.293 -1.337 . . . . 28.07 113.948 -178.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.454 ' HD2' ' HB1' ' A' ' 169' ' ' ALA . 89.1 Cg_exo -49.27 151.4 6.54 Favored 'Trans proline' 0 N--CA 1.447 -1.261 0 O-C-N 123.253 1.133 . . . . 25.56 112.844 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 146.98 -177.7 25.09 Favored Glycine 0 C--O 1.219 -0.843 0 C-N-CA 119.824 -1.179 . . . . 31.26 115.578 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -77.37 153.49 31.21 Favored 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 121.49 1.46 . . . . 41.64 114.264 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 68.97 -120.51 10.75 Favored Glycine 0 C--N 1.347 1.141 0 N-CA-C 117.965 1.946 . . . . 40.28 117.965 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 14.4 tt -68.41 -12.36 15.67 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.702 0 N-CA-C 112.767 0.655 . . . . 42.55 112.767 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -63.98 150.67 44.69 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-O 121.507 0.67 . . . . 36.9 112.366 -178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 78.12 -22.17 3.13 Favored Glycine 0 C--O 1.214 -1.113 0 C-N-CA 120.06 -1.067 . . . . 28.23 114.376 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -64.74 158.06 25.8 Favored 'General case' 0 N--CA 1.446 -0.675 0 CA-C-O 121.341 0.591 . . . . 34.02 112.271 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -137.42 128.79 28.08 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 114.749 -1.114 . . . . 35.07 108.403 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' HIS . . . . . . . . . . . . . 34.8 m170 -114.53 150.35 35.04 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.269 -0.641 . . . . 38.37 109.269 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PHE . . . . . 0.583 ' CE2' ' OE2' ' A' ' 202' ' ' GLU . 61.7 m-85 -129.35 137.45 50.98 Favored 'General case' 0 C--O 1.215 -0.714 0 O-C-N 124.812 1.32 . . . . 40.68 113.304 -177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -74.41 103.78 4.9 Favored 'General case' 0 C--N 1.351 0.643 0 CA-C-N 115.322 -0.853 . . . . 45.33 111.814 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -65.6 -26.06 67.67 Favored 'General case' 0 C--O 1.216 -0.679 0 N-CA-C 113.934 1.087 . . . . 53.78 113.934 -178.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.515 ' OD2' ' HA2' ' A' ' 159' ' ' GLY . 47.4 m-20 -58.6 -13.46 5.82 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-N 115.334 -0.848 . . . . 51.05 112.05 177.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -86.03 165.17 16.89 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.111 -1.07 . . . . 45.57 108.111 177.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLN . . . . . . . . . . . . . 42.1 tp60 -96.36 99.58 11.25 Favored 'General case' 0 C--O 1.217 -0.617 0 N-CA-C 106.304 -1.739 . . . . 64.01 106.304 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 45.4 m95 -80.47 126.25 30.97 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 114.901 -1.045 . . . . 48.68 112.698 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 191' ' ' THR . 26.5 p -135.93 149.77 49.06 Favored 'General case' 0 C--O 1.211 -0.941 0 O-C-N 123.76 0.663 . . . . 51.42 111.024 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -90.76 8.53 34.19 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.981 -1.009 . . . . 86.48 111.102 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -135.18 179.34 6.38 Favored 'General case' 0 C--O 1.217 -0.609 0 C-N-CA 120.443 -0.503 . . . . 68.59 110.978 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 227' ' ' THR . 1.5 m -78.18 51.91 1.05 Allowed 'General case' 0 C--O 1.218 -0.554 0 CA-C-N 115.512 -0.767 . . . . 78.8 112.868 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.451 ' O ' HG21 ' A' ' 187' ' ' THR . 23.4 m -151.06 59.27 0.91 Allowed 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 108.41 -0.959 . . . . 88.97 108.41 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . 147.61 -162.39 28.68 Favored Glycine 0 CA--C 1.493 -1.343 0 N-CA-C 108.869 -1.692 . . . . 72.91 108.869 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 40.6 m -89.56 104.88 17.4 Favored 'General case' 0 C--O 1.199 -1.594 0 C-N-CA 119.557 -0.857 . . . . 57.28 108.915 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.422 ' OD1' ' HB3' ' A' ' 196' ' ' PHE . 16.5 t-20 -58.67 105.53 0.31 Allowed 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 125.562 1.545 . . . . 53.61 113.838 -177.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 30.6 tp -51.51 -41.93 61.36 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-N 114.95 -1.023 . . . . 41.62 112.393 -179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PHE . . . . . 0.692 ' CE1' ' HG3' ' A' ' 119' ' ' LYS . 27.0 t80 -57.07 -57.45 12.53 Favored 'General case' 0 C--O 1.216 -0.677 0 CA-C-O 121.194 0.521 . . . . 36.77 110.805 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.403 ' HG ' ' OD1' ' A' ' 194' ' ' ASN . 93.7 mt -48.23 -48.48 35.14 Favored 'General case' 0 CA--C 1.502 -0.892 0 N-CA-C 113.816 1.043 . . . . 38.23 113.816 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.517 HG13 HG21 ' B' ' 302' ' ' THR . 42.7 t -67.61 -46.41 83.02 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.58 0 C-N-CA 119.401 -0.92 . . . . 36.07 112.677 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.468 ' O ' HG12 ' A' ' 203' ' ' ILE . . . -58.18 -43.97 87.79 Favored 'General case' 0 C--O 1.212 -0.881 0 C-N-CA 119.358 -0.937 . . . . 28.52 109.59 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -54.36 -43.09 71.02 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.243 0.545 . . . . 27.22 111.013 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -65.26 -53.41 44.59 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 114.66 -1.154 . . . . 31.7 110.194 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . 0.583 ' OE2' ' CE2' ' A' ' 180' ' ' PHE . 40.3 mt-10 -59.42 -39.57 83.91 Favored 'General case' 0 C--O 1.215 -0.722 0 N-CA-C 113.565 0.95 . . . . 29.08 113.565 -177.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . 0.531 HG21 HD23 ' A' ' 121' ' ' LEU . 2.5 mm -59.93 -36.98 70.14 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 CA-C-O 121.973 0.892 . . . . 35.0 108.979 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 209' ' ' LEU . . . -52.28 -35.74 43.64 Favored Glycine 0 C--O 1.213 -1.168 0 O-C-N 120.329 -1.482 . . . . 26.18 110.376 177.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -72.76 -40.78 65.73 Favored 'General case' 0 C--O 1.214 -0.81 0 O-C-N 122.285 -0.538 . . . . 31.29 111.561 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' SER . . . . . . . . . . . . . 52.3 p -58.59 -28.7 65.83 Favored 'General case' 0 CA--C 1.507 -0.71 0 O-C-N 123.656 0.598 . . . . 29.49 112.534 176.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' LEU . . . . . . . . . . . . . 73.1 mt -88.62 -12.49 42.42 Favored 'General case' 0 CA--C 1.506 -0.713 0 N-CA-C 114.194 1.183 . . . . 27.39 114.194 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 116.65 10.54 10.18 Favored Glycine 0 C--O 1.219 -0.819 0 N-CA-C 116.853 1.501 . . . . 26.75 116.853 177.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 204' ' ' GLY . 1.4 mp -87.73 159.79 18.34 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.983 0.734 . . . . 29.88 112.983 178.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -117.31 179.05 4.15 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.5 -0.773 . . . . 36.67 108.941 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' HIS . . . . . 0.512 ' CE1' ' O ' ' B' ' 301' ' ' CYS . 7.2 m-70 -71.66 145.71 48.74 Favored 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 119.318 -0.953 . . . . 29.26 110.4 177.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 26.9 t -104.19 155.87 18.37 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.544 -1.207 . . . . 35.16 109.613 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -93.89 -24.47 17.71 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-N 114.762 -1.108 . . . . 47.39 108.285 176.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 64.3 t-20 -64.36 111.6 2.71 Favored 'General case' 0 C--O 1.215 -0.717 0 N-CA-C 107.626 -1.25 . . . . 50.72 107.626 178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 220' ' ' TYR . 37.8 p -59.61 -24.47 63.83 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 114.512 1.301 . . . . 47.4 114.512 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.14 -13.74 56.75 Favored 'General case' 0 C--O 1.219 -0.503 0 O-C-N 123.973 0.796 . . . . 67.68 112.75 178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ALA . . . . . . . . . . . . . . . -78.75 134.9 37.02 Favored 'General case' 0 C--O 1.215 -0.745 0 N-CA-C 112.94 0.718 . . . . 42.19 112.94 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.75 -41.04 63.65 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.083 0.468 . . . . 35.84 110.43 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 80.2 mmm -66.51 4.49 0.75 Allowed 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 115.277 1.584 . . . . 40.82 115.277 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . 0.553 ' CZ ' HG22 ' A' ' 215' ' ' THR . 59.5 t80 -72.59 127.67 89.58 Favored Pre-proline 0 C--O 1.217 -0.619 0 N-CA-C 103.469 -2.789 . . . . 36.39 103.469 173.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -68.36 -30.69 29.67 Favored 'Trans proline' 0 C--O 1.202 -1.309 0 N-CA-C 117.511 2.081 . . . . 31.29 117.511 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' B' ' 303' ' ' CYS . 3.3 mt -71.44 111.17 6.54 Favored 'General case' 0 C--O 1.213 -0.86 0 O-C-N 121.245 -0.909 . . . . 34.61 112.633 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' TYR . . . . . . . . . . . . . 43.7 t80 -57.12 105.66 0.25 Allowed 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 123.689 0.795 . . . . 51.64 112.451 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' HIS . . . . . . . . . . . . . 25.0 m170 -96.53 13.93 26.41 Favored 'General case' 0 C--O 1.22 -0.489 0 N-CA-C 117.693 2.479 . . . . 79.15 117.693 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' SER . . . . . . . . . . . . . 4.0 p 15.4 105.45 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 120.426 3.491 . . . . 69.13 120.426 178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -94.95 145.15 25.12 Favored 'General case' 0 C--O 1.215 -0.722 0 CA-C-O 121.376 0.608 . . . . 76.42 112.597 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' THR . . . . . 0.448 ' HA ' HG21 ' A' ' 190' ' ' THR . 5.3 m -54.55 -85.91 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 116.327 1.973 . . . . 87.39 116.327 -177.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -79.55 113.9 18.06 Favored 'General case' 0 N--CA 1.436 -1.134 0 O-C-N 120.284 -1.51 . . . . 85.17 109.511 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.24 -34.94 79.26 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 113.241 0.83 . . . . 79.35 113.241 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 18.5 m -50.67 -35.18 29.59 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 115.339 1.607 . . . . 91.15 115.339 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 38.2 mtm105 -95.63 28.52 2.97 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 114.808 1.41 . . . . 89.33 114.808 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 46.8 t80 -67.2 138.15 56.76 Favored 'General case' 0 C--O 1.218 -0.583 0 N-CA-C 109.63 -0.507 . . . . 78.88 109.63 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.89 146.61 34.23 Favored 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 115.627 -0.715 . . . . 85.07 110.511 -176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 239' ' ' ILE . 6.3 tp -80.99 146.03 30.89 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-N 115.394 -0.821 . . . . 55.61 109.119 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' SER . . . . . . . . . . . . . 29.9 t -78.5 142.68 37.26 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 118.339 -1.345 . . . . 51.73 107.564 177.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 65.6 tp60 -46.45 -47.96 19.02 Favored 'General case' 0 C--O 1.214 -0.796 0 N-CA-C 106.698 -1.593 . . . . 46.32 106.698 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -46.95 -41.28 15.87 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 114.76 1.393 . . . . 50.84 114.76 -178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -68.69 -37.22 79.39 Favored 'General case' 0 C--O 1.214 -0.807 0 C-N-CA 119.865 -0.734 . . . . 29.49 109.61 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ILE . . . . . 0.484 HG12 HD23 ' A' ' 234' ' ' LEU . 61.3 mt -63.4 -52.07 62.83 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-N 115.522 -0.763 . . . . 27.5 109.27 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -57.25 -34.83 69.01 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 109.01 -0.737 . . . . 34.45 109.01 177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' GLY . . . . . . . . . . . . . . . -66.64 -56.18 14.29 Favored Glycine 0 C--N 1.343 0.932 0 C-N-CA 120.97 -0.633 . . . . 28.94 114.331 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 242' ' ' ILE . 10.1 tp -67.16 -35.99 75.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 114.134 1.161 . . . . 30.41 114.134 -179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLN . . . . . . . . . . . . . 83.8 mt-30 -72.2 -31.58 66.01 Favored 'General case' 0 C--O 1.218 -0.587 0 C-N-CA 119.787 -0.765 . . . . 43.41 112.946 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 18.4 p -62.49 -7.17 4.13 Favored 'General case' 0 C--O 1.217 -0.622 0 CA-C-O 121.703 0.763 . . . . 35.1 112.164 176.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' LEU . . . . . . . . . . . . . 3.2 tp -108.91 -62.02 1.53 Allowed 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 108.5 -0.926 . . . . 33.03 108.5 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -99.48 4.8 46.22 Favored 'General case' 0 C--O 1.219 -0.505 0 N-CA-C 116.975 2.213 . . . . 34.64 116.975 -174.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLY . . . . . . . . . . . . . . . 71.41 167.31 8.12 Favored Glycine 0 C--N 1.342 0.889 0 CA-C-O 118.548 -1.14 . . . . 34.72 112.392 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -85.58 171.12 8.73 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.421 1.61 . . . . 38.66 111.245 177.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -65.83 143.69 74.44 Favored 'Trans proline' 0 N--CA 1.448 -1.179 0 CA-C-N 119.226 0.759 . . . . 49.6 111.555 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 129' ' ' PRO . 50.8 Cg_endo . . . . . 0 C--N 1.357 0.985 0 C-N-CA 124.092 3.195 . . . . 55.17 114.452 179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' CYS . . . . . 0.512 ' O ' ' CE1' ' A' ' 211' ' ' HIS . 42.6 t . . . . . 0 CA--C 1.501 -0.934 0 CA-C-O 121.607 0.717 . . . . 30.8 110.081 . -175.675 113.366 99.563 100.296 2.057 100.774 -68.107 -43.833 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' THR . . . . . 0.517 HG21 HG13 ' A' ' 198' ' ' VAL . 14.1 t -129.21 147.63 51.07 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 105.595 -2.002 . . . . 30.08 105.595 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' CYS . . . . . 0.53 ' O ' ' HA ' ' A' ' 222' ' ' LEU . 4.3 p -167.13 159.74 13.25 Favored 'General case' 0 C--O 1.189 -2.107 0 N-CA-C 118.596 2.813 . . . . 44.0 118.596 -179.23 45.805 171.665 -97.282 93.562 2.062 116.014 -79.2 -29.754 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' VAL . . . . . 0.526 ' O ' HG13 ' B' ' 304' ' ' VAL . 8.0 p -100.26 115.77 65.13 Favored Pre-proline 0 N--CA 1.439 -1.019 0 N-CA-C 105.709 -1.959 . . . . 32.83 105.709 178.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' B' ' 304' ' ' VAL . 32.2 Cg_endo -64.24 162.11 31.39 Favored 'Trans proline' 0 N--CA 1.444 -1.383 0 C-N-CA 120.487 0.791 . . . . 39.45 113.069 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -90.82 159.48 4.1 Favored 'Trans proline' 0 N--CA 1.44 -1.637 0 N-CA-C 109.548 -0.982 . . . . 36.37 109.548 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -70.52 149.96 95.58 Favored Pre-proline 0 N--CA 1.441 -0.892 0 N-CA-C 103.195 -2.891 . . . . 34.84 103.195 172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' PRO . . . . . 0.419 ' HG3' ' CE2' ' B' ' 401' ' ' PHE . 46.4 Cg_exo -51.08 -40.23 59.75 Favored 'Trans proline' 0 C--O 1.213 -0.761 0 O-C-N 116.59 -2.374 . . . . 27.9 115.012 178.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -60.13 -48.02 83.47 Favored 'General case' 0 C--O 1.215 -0.735 0 C-N-CA 119.939 -0.704 . . . . 30.49 112.503 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.97 -34.63 77.93 Favored 'General case' 0 C--O 1.218 -0.588 0 C-N-CA 119.602 -0.839 . . . . 29.09 109.144 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' ALA . . . . . . . . . . . . . . . -59.28 -42.08 90.44 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 109.324 -0.621 . . . . 25.04 109.324 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.84 -46.89 61.89 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 113.032 0.753 . . . . 30.13 113.032 -179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' CYS . . . . . . . . . . . . . 63.7 m -65.88 -50.5 64.27 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 114.496 1.295 . . . . 32.62 114.496 -177.264 -57.164 -66.83 -75.929 103.578 2.031 104.161 -49.168 -62.326 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ASN . . . . . . . . . . . . . 72.5 m-80 -76.11 -15.13 60.15 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 116.593 2.071 . . . . 35.09 116.593 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' SER . . . . . . . . . . . . . 74.9 m -75.94 163.12 27.5 Favored 'General case' 0 CA--C 1.506 -0.749 0 C-N-CA 119.379 -0.929 . . . . 29.75 110.065 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -95.44 -35.39 11.73 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 115.518 -0.765 . . . . 37.98 109.695 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' LEU . . . . . 0.458 HD23 HD13 ' B' ' 319' ' ' ILE . 8.2 mp -135.46 139.92 44.46 Favored 'General case' 0 C--O 1.216 -0.671 0 N-CA-C 108.623 -0.88 . . . . 32.72 108.623 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' VAL . . . . . . . . . . . . . 48.6 t -126.66 89.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.766 0 N-CA-C 102.441 -3.17 . . . . 34.35 102.441 177.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ILE . . . . . 0.485 HD12 ' HG3' ' B' ' 345' ' ' MET . 1.0 OUTLIER -95.15 166.58 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 CA-C-N 111.524 -2.58 . . . . 42.68 111.342 -179.171 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ARG . . . . . . . . . . . . . 3.2 ttp85 -127.14 130.91 50.69 Favored 'General case' 0 C--O 1.22 -0.463 0 N-CA-C 101.423 -3.547 . . . . 39.88 101.423 172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' ALA . . . . . . . . . . . . . . . -160.0 176.95 11.25 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 114.229 1.196 . . . . 34.71 114.229 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' LYS . . . . . . . . . . . . . 45.6 mttt -121.23 144.46 48.6 Favored 'General case' 0 C--O 1.217 -0.641 0 N-CA-C 107.506 -1.294 . . . . 45.62 107.506 178.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -82.66 109.93 17.27 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 115.747 -0.661 . . . . 44.22 110.721 177.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' VAL . . . . . . . . . . . . . 18.8 t -86.28 -35.84 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 124.655 1.222 . . . . 53.29 114.278 -176.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLY . . . . . . . . . . . . . . . -134.99 160.3 24.27 Favored Glycine 0 C--O 1.217 -0.923 0 C-N-CA 118.658 -1.734 . . . . 49.61 115.617 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . 0.537 HG22 ' HD2' ' B' ' 327' ' ' PRO . 0.0 OUTLIER -72.84 153.65 91.16 Favored Pre-proline 0 C--O 1.218 -0.586 0 CA-C-N 114.112 -1.044 . . . . 46.4 110.467 176.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' PRO . . . . . 0.537 ' HD2' HG22 ' B' ' 326' ' ' THR . 17.7 Cg_endo -56.81 136.01 73.9 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 N-CA-C 117.617 2.122 . . . . 44.33 117.617 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.3 138.38 29.49 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 114.077 -1.42 . . . . 65.85 109.322 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' VAL . . . . . 0.534 HG13 ' O ' ' B' ' 332' ' ' THR . 5.2 t -74.91 114.81 15.35 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.595 0 N-CA-C 108.531 -0.914 . . . . 56.13 108.531 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' ASN . . . . . 0.898 ' HB2' ' HD3' ' B' ' 337' ' ' ARG . 26.5 t-20 -74.0 -111.56 0.01 OUTLIER 'General case' 0 C--N 1.35 0.628 0 O-C-N 123.859 0.724 . . . . 53.1 112.762 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLN . . . . . 0.676 ' N ' ' OD1' ' B' ' 330' ' ' ASN . 2.4 pt20 -104.92 25.15 10.83 Favored 'General case' 0 C--O 1.218 -0.562 0 O-C-N 121.497 -0.752 . . . . 58.24 110.716 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' THR . . . . . 0.779 HG22 ' H ' ' B' ' 334' ' ' LEU . 47.5 m -156.0 136.29 13.04 Favored 'General case' 0 C--O 1.21 -1.017 0 CA-C-O 118.636 -0.697 . . . . 50.46 109.783 178.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' THR . . . . . . . . . . . . . 71.7 m -69.92 -23.47 63.23 Favored 'General case' 0 C--O 1.207 -1.173 0 O-C-N 124.091 0.869 . . . . 54.23 112.761 177.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' LEU . . . . . 0.779 ' H ' HG22 ' B' ' 332' ' ' THR . 18.9 mt -70.37 -32.58 70.32 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 116.285 1.957 . . . . 40.93 116.285 -176.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -124.99 146.55 49.36 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 119.591 -0.844 . . . . 39.28 110.469 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -110.69 148.04 33.11 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 104.006 -2.59 . . . . 60.94 104.006 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' ARG . . . . . 0.898 ' HD3' ' HB2' ' B' ' 330' ' ' ASN . 25.9 ptt180 -128.85 149.31 50.81 Favored 'General case' 0 CA--C 1.508 -0.668 0 C-N-CA 118.937 -1.105 . . . . 47.85 113.606 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' TYR . . . . . 0.464 ' HB2' ' CG1' ' B' ' 361' ' ' VAL . 46.7 m-85 -111.83 133.73 53.85 Favored 'General case' 0 C--O 1.216 -0.684 0 O-C-N 124.736 1.273 . . . . 51.43 108.231 178.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -77.78 131.36 37.57 Favored 'General case' 0 C--O 1.219 -0.551 0 N-CA-C 104.412 -2.44 . . . . 63.19 104.412 175.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' ILE . . . . . . . . . . . . . 15.4 pt -130.4 149.5 33.64 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.638 0 O-C-N 123.83 0.706 . . . . 44.14 112.364 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' LYS . . . . . . . . . . . . . 30.6 tptt -106.68 100.43 9.95 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 114.893 -1.049 . . . . 73.27 108.973 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' MET . . . . . . . . . . . . . 3.7 ttp -73.94 119.14 17.74 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 117.481 2.4 . . . . 47.11 117.481 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' THR . . . . . . . . . . . . . 66.9 p -95.06 -77.82 0.46 Allowed 'General case' 0 C--O 1.216 -0.695 0 O-C-N 123.57 0.544 . . . . 46.76 110.983 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.24 141.89 35.12 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 118.677 -0.678 . . . . 66.84 111.156 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' MET . . . . . 0.485 ' HG3' HD12 ' B' ' 319' ' ' ILE . 6.6 ttm -117.59 110.35 17.81 Favored 'General case' 0 C--O 1.217 -0.643 0 N-CA-C 109.586 -0.524 . . . . 36.2 109.586 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' TYR . . . . . . . . . . . . . 64.9 m-85 -85.28 -17.65 36.3 Favored 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 115.047 1.499 . . . . 44.05 115.047 179.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -157.81 151.3 23.62 Favored 'General case' 0 C--O 1.215 -0.724 0 C-N-CA 120.423 -0.511 . . . . 32.99 112.318 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' GLY . . . . . . . . . . . . . . . 103.72 29.93 5.4 Favored Glycine 0 C--N 1.347 1.161 0 CA-C-N 115.14 -0.936 . . . . 43.32 113.655 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -64.15 -3.19 2.52 Favored 'General case' 0 C--O 1.221 -0.443 0 N-CA-C 114.454 1.279 . . . . 57.02 114.454 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.65 37.51 0.88 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 123.558 1.647 . . . . 82.34 108.687 170.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' ALA . . . . . . . . . . . . . . . -163.37 8.89 0.05 Allowed 'General case' 0 C--O 1.214 -0.786 0 C-N-CA 126.601 1.961 . . . . 84.41 112.129 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' LEU . . . . . . . . . . . . 0.25 3.6 mm? 51.84 -106.22 0.26 Allowed 'General case' 0 CA--C 1.474 -1.948 0 N-CA-C 116.062 1.875 . . . . 98.31 116.062 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' GLY . . . . . 0.528 ' O ' ' N ' ' B' ' 355' ' ' ALA . . . 100.22 -44.03 1.68 Allowed Glycine 1 N--CA 1.538 5.444 3 C-N-CA 110.885 -5.436 . . . . 89.8 125.273 -176.214 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 25.66 -66.65 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.672 1 CA-C-N 107.992 -4.104 . . . . 96.53 120.134 -171.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' B' ' 353' ' ' GLY . . . -157.51 -6.14 0.09 Allowed 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 125.139 1.375 . . . . 77.39 111.325 179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' ALA . . . . . . . . . . . . . . . -168.05 45.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 114.378 1.251 . . . . 64.78 114.378 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' ASP . . . . . 0.517 ' HB3' ' HA2' ' B' ' 353' ' ' GLY . 22.6 t0 -104.92 -32.76 8.62 Favored 'General case' 0 C--O 1.213 -0.82 0 C-N-CA 118.929 -1.108 . . . . 72.41 109.152 171.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' ILE . . . . . . . . . . . . . 2.1 mp -96.92 108.84 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.398 0 N-CA-C 101.709 -3.441 . . . . 60.69 101.709 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' ARG . . . . . . . . . . . . . 3.0 mtp180 -119.56 3.99 11.16 Favored 'General case' 0 C--O 1.217 -0.618 0 O-C-N 123.956 0.785 . . . . 83.62 112.912 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.93 137.18 26.01 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 116.392 -0.367 . . . . 58.06 111.21 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.464 ' CG1' ' HB2' ' B' ' 338' ' ' TYR . 5.9 p -115.64 124.56 72.22 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.691 0 N-CA-C 106.135 -1.802 . . . . 35.98 106.135 175.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' TYR . . . . . 0.499 ' O ' HG22 ' B' ' 396' ' ' ILE . 6.0 m-85 -98.41 158.26 15.69 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.612 -0.722 . . . . 49.2 112.155 -179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' THR . . . . . 0.466 ' HB ' ' CG2' ' B' ' 396' ' ' ILE . 14.6 t -161.3 155.56 19.25 Favored Pre-proline 0 N--CA 1.453 -0.291 0 N-CA-C 106.125 -1.805 . . . . 29.05 106.125 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -51.27 157.23 4.67 Favored 'Trans proline' 0 N--CA 1.449 -1.122 0 N-CA-C 115.858 1.445 . . . . 35.29 115.858 176.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -62.61 -33.75 75.63 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 119.698 3.221 . . . . 36.61 119.698 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' MET . . . . . . . . . . . . . 13.7 ptm -131.99 139.88 48.78 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.284 -1.325 . . . . 47.92 113.523 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -49.84 -48.36 51.1 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.287 -0.87 . . . . 26.58 112.003 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' SER . . . . . . . . . . . . . 54.5 p -48.05 -32.69 7.01 Favored 'General case' 0 C--O 1.216 -0.687 0 N-CA-C 112.817 0.673 . . . . 28.95 112.817 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' VAL . . . . . 0.494 ' O ' HG13 ' B' ' 369' ' ' VAL . 0.3 OUTLIER -104.92 27.0 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.614 0 N-CA-C 113.887 1.069 . . . . 29.93 113.887 -179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' CYS . . . . . . . . . . . . 0.337 7.9 m 91.94 6.81 0.06 Allowed 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 121.52 3.896 . . . . 35.82 121.52 174.646 -43.833 -68.107 99.563 100.774 2.057 100.296 113.366 -175.675 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLY . . . . . . . . . . . . . . . -61.32 139.8 47.53 Favored Glycine 0 C--O 1.215 -1.051 0 C-N-CA 119.766 -1.207 . . . . 31.52 111.337 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -84.39 140.32 31.64 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-N 117.464 0.632 . . . . 39.89 111.157 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -119.92 107.71 13.46 Favored 'General case' 0 C--N 1.351 0.637 0 N-CA-C 115.285 1.587 . . . . 42.52 115.285 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -97.07 124.45 41.08 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 115.445 1.646 . . . . 49.33 115.445 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.05 74.06 1.46 Allowed 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 115.582 1.697 . . . . 76.83 115.582 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' SER . . . . . . . . . . . . . 12.6 m -111.18 152.05 27.5 Favored 'General case' 0 C--O 1.206 -1.23 0 O-C-N 121.345 -0.847 . . . . 79.91 110.081 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' HIS . . . . . 0.598 ' H ' ' CD2' ' B' ' 377' ' ' HIS . 0.3 OUTLIER -79.75 -38.6 32.91 Favored 'General case' 0 C--O 1.218 -0.585 0 C-N-CA 126.473 1.909 . . . . 93.97 116.018 -178.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -103.76 114.44 28.71 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 122.852 0.461 . . . . 82.61 110.085 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' ARG . . . . . . . . . . . . . 5.9 mtt85 -69.92 -19.98 63.37 Favored 'General case' 0 C--O 1.217 -0.642 0 N-CA-C 117.769 2.507 . . . . 95.15 117.769 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' SER . . . . . . . . . . . . . 58.0 m -78.95 -5.09 52.89 Favored 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 113.37 0.878 . . . . 84.09 113.37 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -63.07 143.05 58.12 Favored 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 115.826 -0.624 . . . . 71.34 110.697 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -104.97 141.05 37.25 Favored 'General case' 0 C--O 1.215 -0.73 0 N-CA-C 115.023 1.49 . . . . 60.79 115.023 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -122.61 156.89 33.33 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 113.541 -1.663 . . . . 45.22 114.394 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -108.08 112.79 25.51 Favored 'General case' 0 C--O 1.212 -0.915 0 N-CA-C 103.378 -2.823 . . . . 35.22 103.378 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' ILE . . . . . . . . . . . . . 61.4 mt -112.25 119.17 59.56 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.61 0 N-CA-C 106.632 -1.618 . . . . 22.07 106.632 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 386' ' ' ALA . . . . . . . . . . . . . . . -107.6 112.94 25.91 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 105.584 -2.006 . . . . 23.96 105.584 175.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 387' ' ' GLY . . . . . . . . . . . . . . . -136.42 171.8 22.73 Favored Glycine 0 C--O 1.215 -1.033 0 C-N-CA 118.439 -1.839 . . . . 24.77 116.088 -176.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 388' ' ' LYS . . . . . . . . . . . . . 30.1 mmtt -99.46 169.41 9.34 Favored 'General case' 0 C--O 1.214 -0.776 0 CA-C-N 114.399 -0.901 . . . . 36.06 110.288 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 389' ' ' LEU . . . . . . . . . . . . . 16.7 mt -120.8 99.46 6.54 Favored 'General case' 0 C--O 1.22 -0.479 0 C-N-CA 120.425 -0.51 . . . . 47.22 109.786 -178.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 390' ' ' GLN . . . . . 0.408 ' O ' ' HB2' ' B' ' 391' ' ' ASP . 38.6 tt0 -89.29 125.19 35.01 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 102.127 -3.286 . . . . 65.61 102.127 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 391' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' B' ' 390' ' ' GLN . 38.1 m-20 65.01 -126.42 0.37 Allowed 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 103.451 -2.796 . . . . 72.94 103.451 -173.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 392' ' ' GLY . . . . . . . . . . . . . . . -115.6 21.04 13.03 Favored Glycine 0 N--CA 1.434 -1.448 0 N-CA-C 109.094 -1.603 . . . . 51.74 109.094 176.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 393' ' ' LEU . . . . . . . . . . . . . 28.2 mt -108.71 138.1 45.59 Favored 'General case' 0 C--O 1.209 -1.06 0 N-CA-C 114.886 1.439 . . . . 43.55 114.886 -176.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 394' ' ' LEU . . . . . . . . . . . . . 26.5 tp -77.48 123.9 27.17 Favored 'General case' 0 CA--C 1.504 -0.811 0 CA-C-N 115.244 -0.889 . . . . 31.91 109.86 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 395' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -115.34 149.54 37.73 Favored 'General case' 0 C--O 1.218 -0.589 0 O-C-N 124.372 1.045 . . . . 35.25 109.61 178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 396' ' ' ILE . . . . . 0.702 HD11 HG21 ' B' ' 402' ' ' VAL . 2.0 tt -136.34 155.48 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 CA-C-N 112.367 -2.197 . . . . 41.55 106.534 -177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 397' ' ' THR . . . . . . . . . . . . . 28.4 p -144.07 178.12 8.09 Favored 'General case' 0 N--CA 1.425 -1.697 0 CA-C-N 121.417 1.917 . . . . 32.75 109.094 176.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 398' ' ' THR . . . . . . . . . . . . . 7.9 m -51.63 -31.64 26.09 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 113.459 0.911 . . . . 32.72 113.459 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 399' ' ' CYS . . . . . 0.461 ' SG ' HG22 ' A' ' 163' ' ' VAL . 1.6 m -92.37 -24.99 18.72 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-N 115.125 -0.943 . . . . 46.65 112.76 -176.714 -29.754 -79.2 -97.282 116.014 2.062 93.562 171.665 45.805 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 400' ' ' SER . . . . . . . . . . . . . 72.9 m -44.52 136.09 4.43 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 119.581 -0.848 . . . . 23.74 110.545 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 401' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' B' ' 308' ' ' PRO . 20.3 t80 -71.08 107.01 3.93 Favored 'General case' 0 C--O 1.219 -0.541 0 O-C-N 124.145 0.903 . . . . 20.92 109.953 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 402' ' ' VAL . . . . . 0.702 HG21 HD11 ' B' ' 396' ' ' ILE . 99.2 t -135.43 117.35 20.91 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.139 0 N-CA-C 106.886 -1.524 . . . . 31.76 106.886 177.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 403' ' ' ALA . . . . . . . . . . . . . . . -148.09 149.0 31.38 Favored Pre-proline 0 CA--C 1.508 -0.645 0 N-CA-C 106.566 -1.642 . . . . 40.59 106.566 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 404' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -65.0 135.19 42.93 Favored 'Trans proline' 0 N--CA 1.443 -1.483 0 CA-C-N 119.644 0.909 . . . . 38.73 110.613 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 405' ' ' TRP . . . . . 0.439 ' O ' ' HB2' ' B' ' 408' ' ' LEU . 75.8 t-105 -49.29 -43.41 43.21 Favored 'General case' 0 C--O 1.21 -1.015 0 CA-C-O 122.333 1.063 . . . . 51.27 113.776 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 406' ' ' ASN . . . . . 0.406 ' HA ' HH21 ' B' ' 413' ' ' ARG 0.36 78.6 m-20 -61.16 -21.3 63.65 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 119.487 3.143 . . . . 53.86 119.487 178.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 407' ' ' SER . . . . . . . . . . . . . 93.5 p -86.75 -17.35 33.8 Favored 'General case' 0 C--O 1.216 -0.658 0 CA-C-N 114.591 -1.186 . . . . 41.13 110.522 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 408' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' B' ' 405' ' ' TRP . 0.4 OUTLIER -67.8 131.62 45.88 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 115.738 1.755 . . . . 40.43 115.738 -179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 409' ' ' SER . . . . . . . . . . . . . 70.8 p -62.8 160.53 14.29 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.037 -1.097 . . . . 37.43 108.037 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 410' ' ' LEU . . . . . 0.721 ' H ' HD12 ' B' ' 410' ' ' LEU . 4.2 mp -62.67 -35.14 78.72 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 107.92 -1.141 . . . . 41.85 107.92 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 411' ' ' ALA . . . . . . . . . . . . . . . -63.99 -56.59 13.99 Favored 'General case' 0 C--O 1.216 -0.673 0 O-C-N 123.949 0.78 . . . . 41.54 109.362 178.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 412' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -52.67 -42.04 64.37 Favored 'General case' 0 C--O 1.218 -0.566 0 O-C-N 123.22 0.325 . . . . 47.34 111.813 179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 413' ' ' ARG . . . . . 0.406 HH21 ' HA ' ' B' ' 406' ' ' ASN . 63.5 mtt85 -58.72 -48.62 80.52 Favored 'General case' 0 C--O 1.216 -0.68 0 N-CA-C 109.05 -0.722 . . . . 58.57 109.05 179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 414' ' ' ARG . . . . . . . . . . . . . 12.4 tpt180 -61.17 -34.3 74.82 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-N 115.281 -0.872 . . . . 71.04 112.625 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 415' ' ' GLY . . . . . . . . . . . . . . . -67.5 -48.06 59.27 Favored Glycine 0 C--N 1.343 0.918 0 N-CA-C 110.233 -1.147 . . . . 29.29 110.233 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 416' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -61.73 -43.28 99.16 Favored 'General case' 0 CA--C 1.507 -0.68 0 C-N-CA 119.225 -0.99 . . . . 35.85 111.304 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 417' ' ' THR . . . . . . . . . . . . . 2.4 m -70.86 -37.62 73.11 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 114.932 1.456 . . . . 36.43 114.932 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 418' ' ' LYS . . . . . 0.409 ' HB2' ' HE2' ' B' ' 418' ' ' LYS . 11.0 tppt? -135.94 -46.09 0.65 Allowed 'General case' 0 C--N 1.35 0.63 0 N-CA-C 119.955 3.317 . . . . 63.83 119.955 -176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 419' ' ' THR . . . . . . . . . . . . . 5.3 p -85.39 -27.06 26.06 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 121.787 3.995 . . . . 43.94 121.787 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 420' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -58.06 -41.03 82.49 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-N 120.822 1.646 . . . . 27.68 114.935 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 421' ' ' THR . . . . . . . . . . . . . 1.3 p -50.02 -41.73 47.95 Favored 'General case' 0 C--O 1.217 -0.637 0 CA-C-O 121.087 0.47 . . . . 26.92 111.434 178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 422' ' ' VAL . . . . . . . . . . . . . 46.2 t -50.16 -34.8 11.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.557 0 CA-C-N 115.141 -0.936 . . . . 29.04 112.933 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 423' ' ' GLY . . . . . . . . . . . . . . . -95.86 -1.21 61.72 Favored Glycine 0 C--O 1.219 -0.818 0 C-N-CA 118.664 -1.732 . . . . 27.23 116.264 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 424' ' ' CYS . . . . . . . . . . . . . 71.3 m -67.3 -54.57 19.56 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 119.491 3.145 . . . . 36.66 119.491 -174.272 -62.326 -49.168 -75.929 104.161 2.031 103.578 -66.83 -57.164 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 425' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -66.43 -22.99 66.23 Favored 'General case' 0 C--O 1.221 -0.444 0 N-CA-C 116.006 1.854 . . . . 81.49 116.006 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.513 -0.476 0 N-CA-C 114.586 1.328 . . . . 52.82 114.586 -174.765 . . . . . . . . 1 1 . 1 stop_ save_